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Stellingen (Propositions) 
1. The efficacy of iodized peanut oil is greater than that of iodized 
poppyseed oil in combating iodine deficiency (this thesis). 
2. Although many indicators have been used to assess whether and to 
what extent a population is iodine deficient and to monitor the 
effectiveness of iodine deficiency control programs, urinary iodine 
concentration and thyroid volume measured by ultrasound are the most 
suitable (this thesis). 
3. Iodine deficiency disorders are recognized not only as a public health 
nutrition issue, but also as an obstacle to human development (this 
thesis). 
4. The development of cognitive performance of stunted school children is 
less than that of their non-stunted counterparts (this thesis). 
5. Non-iodized salt available in the market which is cheaper than iodized 
salt, may subvert the effectiveness of iodized salt in combating iodine 
deficiency (this thesis). 
6. Simple goiter is the easiest of all known diseases to prevent. It may be 
excluded from the list of human diseases as soon as society 
determines to make the effort (D Marine. Prevention and treatment of 
simple goiter, Atl. Med. J. 1923; 26: 437-443). 
7. When the twentieth century ends, it would be satisfying to be able to 
look back and say: "That was the century when iodine deficiency was 
eliminated from the face of our planet". 
8. Selling iodized salt to a population with endemic iodine deficiency is not 
like marketing 'Coca-Cola'. 
9. Cybernet enables people to contact others all over the world within 
seconds, but reduces meaningful contact between people. 
10. Significant is not always relevant. 
11. Learning does not end with the completion of formal education. 
Learning is a lifelong experience for those with an appetite for 
knowledge. 
12. There is nothing wrong with having different opinions, but it's absolutely 
wrong to enforce one's opinion, no matter what the reason. 
13. There is only one way to fight violence with nonviolence: education 
(Dalai Lama). 
14. For everything we have missed, we have gained something else; and 
for everything we gain, we lose something else (Ralph W Emerson. 
Nature, Addresses and Lectures. Harvard Divinity School, 1849). 
Proefschrift Juliawati Untoro 
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Abst ract 
Use of oral iodized oil to control iodine deficiency in Indonesia 
PhD thesis by Juliawati Untoro, Division of Human Nutrition and Epidemiology, 
Wageningen Agricultural University, the Netherlands. 
Iodine deficiency is a leading cause of preventable mental retardation and 
universal salt iodization has been adopted as the main strategy for its control. 
However additional strategies are required where iodized salt cannot be made 
available in the short term or only with difficulty in the long term. Oral iodized oil 
supplementation is useful for this purpose. The aim of the work described in this 
thesis was to compare the efficacy of different preparations of oral iodized oil for 
controlling iodine deficiency. In addition, the performance of different outcome 
indicators of iodine deficiency, the impact of nutritional status and iodine 
supplementation on cognitive performance, as well as the effectiveness of salt 
iodization in the population were investigated. The studies were carried out in school 
children aged 8-10 y living in an endemic iodine deficient area in Indonesia. 
A single oral dose of iodized oil prepared from peanut oil which is rich in oleic 
acid resulted in three times higher retention of iodine and twice the length of 
protection than iodized oil prepared from poppyseed oil which has less oleic acid 
and more linoleic acid. Thus iodized oils based on oleic acid rich oils should be given 
preference to iodized poppyseed oil in programs to control iodine deficiency. 
Urinary iodine concentration and thyroid volume measured by ultrasound 
were found to be the most useful indicators for assessing iodine status and 
measuring the impact of iodized oil supplementation among iodine deficient school 
children. However thyroid palpation still has a useful place in assessing iodine status 
because no sophisticated equipment is required. Iodine status as measured by 
urinary iodine concentration at baseline and stunting were found to be related to the 
improvement of cognitive performance when children were dosed with iodized oil. 
The use of iodized salt, which was correlated with urinary iodine concentration and 
thyroid volume, resulted in improvement of the iodine status of the population 
studied. Apart from promulgation enabling legislation, much effort needs to be 
expended to increase the success of salt iodization for controlling iodine deficiency. 
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General introduction 
Chapter 1 
IODINE DEFICIENCY: MAGNITUDE OF THE PROBLEM AND ITS 
CONSEQUENCES 
Iodine deficiency is the world's leading cause of preventable mental 
retardation. Up until the begin of the 1990s, it was regarded as being a significant 
public health problem in 118 countries with 1600 million people at risk (1). In 1990 
the World Summit for Children, at United Nations Headquarters in New York, set the 
goal for the elimination of iodine deficiency disorders (IDD) by the year 2000. Since 
then, reduction in iodine deficiency is a global success story by any standard. This 
achievement involved a coordinated international effort to change diets in a subtle 
but important way by the introduction of iodized salt (2). UNICEF estimates that 
nearly 60 per cent of all edible salt in the world is now iodized. Of the countries that 
had iodine deficiency at the beginning of the decade, 26 now iodize over 90 per cent 
of their edible salt or import that proportion if they are not salt producers. Another 14 
countries iodize between 75 per cent and 90 per cent of their salt. As late as 1994, 
48 countries with established iodine deficiency still had no programs at all. Of these, 
14 now iodize more than half of their salt (2). Although iodization of salt has been 
successful in reducing the prevalence of iodine deficiency, additional strategies are 
required to eradicate iodine deficiency. Probably the best alternative is oral dosing 
with iodized oil which is the subject of this thesis. 
Although goiter is the most manifest sign, iodine deficiency results in 
irreversible brain damage in the fetus and infant, retarded mental and psycho-motor 
development in the child, and also impaired reproductive function (3-11). In the most 
severe cases, it leads to cretinism. The cumulative consequences in iodine deficient 
populations spell diminished performance for the entire economy. In Indonesia, IDD 
comprise one of the most important malnutrition problems with high rates of goiter 
prevalence being reported (Table 1). 
The main cause of IDD is inadequacy of iodine intake due to environmental 
deficiency of this essential element. This interacts with poverty and remoteness 
when there is little contribution of food from outside an iodine deficient area to the 
diet, as is the case with much subsistence agriculture. Poverty, with poor sanitation 
and general malnutrition, may worsen the effects of iodine deficiency. Inadequacy of 
iodine intake is the major but not the sole factor responsible for IDD. The importance 
of other factors in causing iodine deficiency including goitrogenic substances, 
protein energy malnutrition (PEM), vitamin A and selenium deficiencies, has been 
revealed by several studies. 
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Table 1. General overview of iodine status in Indonesia 
Period of investigation Indicator 
1980-1982(12) Prevalence of goiter, 11.3-74.7 % 
People at risk, 30 million 
Estimated number of cretins, 750,000 
1987-1990 (12) Prevalence of goiter, 2.8-62.2% 
1983-1984 (13) Adequately iodized salt (> 30 ppm), 
33.0% 
1995 (14) Adequately iodized salt (> 30 ppm), 
49.8% 
Goitrogenic substances play a role in the etiology of IDD in humans (15-17). 
Natural goitrogens were first found in vegetables of the genus Brassica (the 
Cruciferae family). Their anti-thyroid action is related to the presence of 
thioglucosides, which after digestion release thiocyanate (SCN) and isothiocyanate 
(18). These compounds are powerful goitrogenic agents that act by inhibiting thyroid 
iodide transport and at high doses, compete with iodide in the organification process 
(15). Another important group of natural goitrogens is the cyanoglycosides, which 
are found in several staples (cassava, maize, bamboo shoots, sweet potatoes) (19). 
After ingestion, these glycosides release cyanide (CN) which is detoxified by 
conversion to thiocyanate. A cassava-based diet combined with a low iodine supply 
produces marked differences in the prevalence of goiter, such differences are 
determined by the balance between iodide and thiocyanate concentrations in the 
blood reaching the thyroid and in the thyroid itself (19). 
Severe PEM affects thyroid function and the metabolism of thyroid hormones. 
Iodine malabsorption may be associated with PEM and thus contribute to endemic 
goiter, particularly where iodine intake is limited (20-22). 
Selenium has been shown to be an essential component of iodothyronine 5'-
deiodinase type I, II and III (23,24). Thyroxine (T4), the major hormone product of the 
thyroid gland, is converted to the more biologically active hormone 3,5,3'-
triiodothyronine by type I and type II iodothyronine 5'-deiodinase (25). The type III 
iodothyronine deiodinase converts T4 and T3 into inactive reverse-T3 and 
diiodothyronine respectively, by catalyzing the inner ring deiodination (26,27). 
Therefore, selenium-deficient subjects have low tissue deiodinase activities and 
abnormal thyroid hormone metabolism (23,28). 
The role of vitamin A in IDD was studied by Horvart and Maver (29) on the 
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island of Krk, Yugoslavia. The prevalence of goiter in a group of school children was 
decreased by 45% in those who received 3,000 lU/d vitamin A supplementation 
while it remained the same in a control group which was not supplemented. A study 
by Ingenbleek and de Visscher (30) has also shown that vitamin A affects iodine 
metabolism. They found that the concentration of transthyretin, retinol-binding 
protein and retinol levels decreased progressively with increase in goiter size while 
serum albumin levels and urinary iodine concentration were low in the goitrous 
subjects in Senegal. Wolde-Gebriel et al. (31) showed that Ethiopian children with 
goiter grade IB and II had lower serum retinol and retinol-binding protein levels 
compared with those with no goiter or grade IA goiter. 
IODINE METABOLISM 
Most of the iodine in the human body enters the circulation as iodide, where it 
becomes part of the iodine pool (32). The healthy adult human body contains 15-20 
mg of iodine of which about 70-80% is in the thyroid gland which weighs only 15-25 
g. Thus, the pool of iodine is concentrated mainly in the thyroid. The remainder is in 
tissues or in the circulation either as free iodine or protein-bound iodine. 
The normal intake and requirement for children and adults are 100-150 ng per 
day. Excess iodide is readily excreted by the kidney. The level of excretion 
correlates well with the level of intake so that it can be used to assess the level of 
iodine intake (33). The thyroid has to trap about 60 ^g of iodine per day to maintain 
an adequate supply of T4. This is possible because of the very active iodide trapping 
mechanism which enables the thyroid to maintain concentration gradients for iodide 
(thyroid/plasma concentration ratios) of about 100 (34). In iodine deficiency, this 
gradient may exceed 400 in order to maintain the output of T4. The amount of iodine 
in the gland is closely related to iodine intake and the content may drop to 1 mg or 
less in the iodine deficient thyroid gland (35). 
About half of the iodine in the diet, absorbed from the intestine as inorganic 
iodide, is normally taken up by the thyroid gland (the rest is excreted in urine) and 
there incorporated into protein (thyroglobulin, Tg) to form mono- and di-iodothyrosine 
(MIT and DIT), precursors of tetraiodothyronine (T4) and triiodothyronine (T3). These 
hormones are then released into the blood, often over quite long periods, in 
response to various stimuli controlled by thyroid stimulating hormone (TSH). TSH 
which is secreted by the anterior pituitary, is the principal active regulator and 
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accelerates iodoprotein synthesis. The release of TSH is stimulated by thyrotropin 
releasing hormone (TRH), which is produced by the hypothalamus. Both TRH and 
TSH secretion are triggered by a decline in blood thyroid hormone levels, so the 
system maintains these blood concentrations at functional levels over a wide range 
of iodine status (34). 
Iodine exists in the blood as T4, T3 and as inorganic iodine. The level of 
inorganic iodine falls in iodine deficiency and rises with increased intake. T4 is the 
major form of thyroid hormone secreted by the thyroid: it is converted to either T3 or 
reverse T3 (rT3). The T4 and T3 are mainly (>99%) bound to three plasma proteins 
i.e.: thyroxine binding globulin, thyroxine binding prealbumin and albumin, and only 
about 0.5 percent is free in human serum. In the bound state, T4 and T3 are not 
biologically active. It is the concentration of unbound hormone which determines the 
level to which the target cells are exposed (34). Thus the level of free T4 is an 
important determinant of tissue levels of thyroid hormone and is necessary for the 
brain. Determination of the level of free T4 in serum is the optimum method for 
assessment of thyroid status and for the diagnosis of hypothyroidism and 
hyperthyroidism (36). A study in iodine deficient rats showed that low fetal brain T3 
increased the activity of 5' deiodinase II activity (37), this means that the developing 
fetal brain is highly dependent on a supply of T4 because it is converted to T3 by 
intracellular deiodination (38). 
The synthesis and availability of the thyroid hormone is reduced in iodine 
deficiency. Hence blood levels of T4 and FT4 as well as of TSH and Tg, can be used 
for assessing thyroid status. Although much of the basic physiology of thyroid 
hormones and effects of deficiency of thyroid hormones are reasonably understood 
and well-described, the mechanism of action of the hormones, and hence the 
pathological effects of deficiency, remain to be fully worked out (36). 
INDICATORS FOR ASSESSING THE EXTENT OF IDD IN POPULATIONS 
Indicators are essential for measuring the extent of iodine deficiency, whether 
and which intervention is necessary and for evaluating program implementation and 
impact. Indicators can be classified as: outcome indicators which provide a measure 
of iodine status, and process indicators which measure progress in implementing an 
IDD control program. The outcome indicators can be further classified according to 
whether the assessment is clinical or biochemical. WHO/UNICEF/ICCIDD (39) 
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generally recommends that at least two indicators should be used. No single 
parameter reflects the entire IDD picture and resulting changes in the thyroid. In 
cases of severe deficiency, initial emphasis may be on lowering rates of goiter and 
cretinism. Even though several indicators to evaluate the extent of iodine deficiency 
are established, further study on specificity and sensitivity of outcome indicators 
among iodine deficient population are still needed. Therefore in this thesis outcome 
indicators for determining iodine status are examined. 
Outcome indicators: clinical. 
Thyroid Size. The size of the thyroid gland changes inversely in response to 
alterations in iodine intake. Thyroid size can be determined by palpation and 
ultrasonography. The preferred target group is children aged 8-10 years but can be 
extended to children aged 6-12 years old. There is a practical reason for not 
measuring very young age groups: the smaller the child, the smaller the thyroid and 
the more difficult it is to perform palpation, and the consideration for not measuring 
the older group is the puberty period. The classification of goiter currently used is as 
follows (39): 
Grade 0 : No palpable or visible goiter. 
Grade 1 : A mass in the neck that is consistent with an enlarged thyroid that is 
palpable but not visible when the neck is in the normal position. It 
moves upward in the neck as the subject swallows. Nodular 
alteration(s) can occur even when the thyroid is not visibly enlarged. 
Previously grade 1 goiter was divided into IA (palpable) and IB (visible 
with neck extended). 
Grade 2 : A swelling in the neck that is visible when the neck is in the normal 
position and is consistent with an enlarged thyroid when the neck is 
palpated. Previously grade 2 goiter was divided into II (visible at close 
range with head in normal position) and III (visible at distance with 
head in normal position). 
Palpation is quantitative only in the crude sense. Total goiter rate describes 
the proportion of total goiter grade 1 and 2 in the population. Specificity and 
sensitivity of palpation are low in grades 0 and 1 due to a high inter-observer 
variation, misclassification can be as high as 40%, especially but not exclusively in 
the assessment of smaller enlargements of the thyroid. Low goiter rates, especially 
when found following a sustained intervention, should be confirmed by ultrasound, 
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which provides a more objective measure of thyroid size (39-43). However, there are 
several advantages of palpation as a method of measurement. It is a technique that 
requires no instrumentation, can reach large numbers in a short period of time, is not 
invasive and makes relatively limited demands on the skills of the observer. 
Nevertheless, the ease with which accurate palpation can be conducted has been 
seriously overestimated in some instances as inadequately trained observers have 
been used (44). 
Ultrasonography is a means of obtaining an image of the thyroid and can 
provide a more accurate assessment of thyroid size. This assessment also requires 
a trained operator, expensive equipment, and is not often practical for routine use in 
surveys. Ultrasonography provides a more precise measurement of thyroid volume 
than palpation and this becomes especially significant when the prevalence of 
visible goiter is small, and in monitoring iodine control programs where thyroid 
volumes are expected to decrease over time (43). The thyroid volume is calculated 
based on the length, width, and thickness of both lobes using an ellipsoid model 
(45). The calculated volume should be compared to the normative standard of a 
population with sufficient iodine intake (46). In iodine replete populations, the 
expected prevalence of thyroid volumes greater than the 97th centile would be 3%, 
and this figure can be compared with the observed prevalence. In addition, the 
median (50lh centile) thyroid volume may be useful. 
Cretinism. Endemic cretinism, which is the most dramatic consequence of 
iodine deficiency, is caused by thyroid hormone deficiency during development of 
the central nervous system during the prenatal period. The manifestation of endemic 
cretinism include mental retardation, severe growth retardation, squinting of eyes 
and deafness. 
Outcome indicators: biochemical 
Serum thyroid hormones. Measurement of thyroid hormones in blood might 
provide the ultimate tools for measuring IDD. Laboratory methods, usually 
radioimmunoassay techniques, exist for measuring blood levels of the major thyroid 
hormones, T4, FT4, T3, Tg and TSH. While providing some important information, 
they have the disadvantages of being expensive, being generally unavailable in 
many developing countries, and requiring the collection of blood samples. 
Urinary iodine concentration. Almost all iodine in the body is eventually 
excreted in the urine. Thus measurement of iodine in the urine provides a good 
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index of the iodine ingested. However, since an individual's level of urinary iodine 
varies daily and even during a given day, data can be used only for making a 
population-based estimate. The iodine concentration in early morning urine 
specimens (child or adult) provides an adequate assessment of a population's iodine 
status; 24-hour samples are not necessary. Urinary iodine concentration is 
preferably expressed per liter of urine (100 u.g/L is equivalent to 0.79 |imol/l_) rather 
than per gram of creatinine (47). Furnee et al. (47) found that the iodine-creatinine 
ratio in casual urine samples is an unsuitable indicator for evaluating iodine status in 
areas where large inter and intra individual variations in urinary creatinine 
concentration exist. A model for describing urinary iodine after oral dosing of iodized 
oil was developed by Furnee et al. (48), which reflects the mutual effects of the 
physiological mechanism involved in the retention and elimination of iodine. 
Epidemiological criteria for assessing the severity of IDD 
A summary of cut-off points and prevalence that are considered indicative of 
a significant public health problem for IDD is presented in Table 2. 
Table 2. Summary of IDD prevalence indicators (outcome indicators) and criteria for a 
significant public health problem a 
Indicator Target population Severity of public health problem 
Mild Moderate Severe 
Total goiter (by palpation, %) or School age children, 5.0-19.9 20.0-29.9 >30.0 
thyroid volume > 97th centile by 6-12 y 
ultrasound3 (%) 
Median urinary iodine level School age children, 50-99 20-49 < 20 
(ng/L)b 6-12 y 
TSH > 5 mU/L whole blood (%) Neonates, 4-30 days 3.0-19.9 20.0-39.9 > 40.0 
Median Tg (ng/mL serum)c Children and adults, 10.0-19.9 20.0-39.9 > 40 0 
>1y 
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Based on WHO/UNICEF/ICCIDD (39) modified by WHO/ICCIDD (46). 
Conversion factor: 100 ng/L = 0.79 (imol/L 
No international standards are yet available for this assay so criteria need to be 
established in each laboratory (49). 
General introduction 
With the epidemiological criteria for establishing IDD severity, it should be 
understood that "mild" is a relative term; it does not imply that this category of IDD is 
of little consequence. With respect to goiter, a total goiter rate (goiter grades 1 and 
2) of 5% or more in primary school children (age range approximately 6 to 12 years) 
signals the presence of a public health problem. This is based on the observation 
that in a normal iodine-replete population, the prevalence of goiter should be quite 
low. The cut-off of 5% allows some margin of inaccuracy of goiter assessment and 
for goiter that may occur in iodine-replete population due to other causes such as 
goitrogens and autoimmune thyroid diseases. The previously recommended 10% 
cut-off level has been revised downwards since it has been shown that goiter 
prevalence rates between 5% and 10% may be associated with a range of 
abnormalities, including inadequate urinary iodine concentration and/or abnormal 
levels of TSH among adults, children and neonates (39). 
With respect to urinary iodine concentration, frequency distribution curves are 
necessary for full interpretation, since values from populations are usually not 
normally distributed, and therefore the median value is used rather than the mean. 
Iodine deficiency is indicated when the median value for iodine concentration in 
urine is less than 0.79 |amol/L, i.e. when 50% of the samples have values less than 
0.79 nmol/L 
The specificity of TSH for IDD screening has not been clearly quantified. 
Individuals with mild elevations of TSH can now be detected by using the newer 
sensitive whole-blood TSH assay. IDD screening programs are not designed to 
follow up individuals but to direct population-based interventions. Reference data for 
TSH are available among neonates because they are routinely collected as part of 
neonate congenital hypothyroid screening programs. TSH values are currently in 
whole blood units or serum units. A TSH cut-off point of 20-25 mU/L whole blood 
(approximately 40-50 mU/L serum) is commonly used to screen for congenital 
hypothyroidism. IDD may present with TSH levels which are only mildly elevated. 
While further study of iodine-replete populations is needed, a cut-off of 5 mU/L in 
whole blood is regarded as appropriate for epidemiological studies of IDD in 
neonates. 
Individuals (children and adults) with sufficient iodine intake show a median 
Tg serum level of 10 ng/ml and a normal upper limit, for individuals, of 20 ng/ml in 
most assay techniques. The results obtained from a survey should be expressed as 
a median and as the percentage of Tg levels above 20 ng/ml (39). However it should 
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be noted that no international standards are yet available for this assay so criteria 
need to be established in each laboratory (49). 
Process indicators of IDD control programs 
As programs are implemented for the control of IDD in a country, it is 
important to establish mechanisms for monitoring and evaluating these activities. 
Included in such monitoring protocols will be both indicators associated with the 
process of the programs, as well as indicators of the impact realized through the 
implementation of the control activities. Depending upon the specific characteristics 
of the IDD control programs, distinct indicators will need to be considered and 
different techniques employed in their monitoring. Although most countries will have 
iodized salt as the primary control activity, other programs, where implemented, will 
need to be monitored, even if they are used as short-term measures while salt 
iodization is being established. 
Salt iodization programs. All countries with a significant public health IDD 
problem should undertake a situation analysis of salt available for human and animal 
consumption, from points of production (or importation) through distribution channels 
to the consumption level. Such salt is referred to as food grade salt, which includes 
crude salt for direct edible use by people, and for livestock; and refined salt for 
edible use and for use in most processed foods (50). 
The iodization of salt involves the addition of a small quantity of iodine (30 to 
100 mg of iodine per kg salt, or parts per million - ppm), usually in the form of 
potassium iodide or potassium iodate. The joint FAO/WHO Expert Committee on 
Food Additives noted in 1991 that "potassium iodate has been shown to be a more 
suitable substance for fortifying salt than potassium iodide, because of its greater 
stability, particularly in warm, damp or tropical climates" (51). 
Iodized oil programs. The program evaluation should permit a monitoring of 
periodic recording of distribution of the oral iodized oil capsules and assess an 
output e.g. number of people at risk of iodine deficiency receiving the capsules. 
INDONESIAN IDD CONTROL PROGRAMS 
The Government of Indonesia has endorsed the goals of the 1990 World 
Summit for Children and the recommendations of the 1991 World Health Assembly 
for the elimination of IDD by the year 2000. To attain the goal that by the year 2000 
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no cretinious baby will be born, the IDD National Program in Indonesia has 
established the following strategies (52). 
Iodized salt for human consumption. To strengthen the iodized salt program, 
the government issued a joint decree of four Ministries (Industry, Health, 
Trade and Home Affairs), that all salt for human consumption in Indonesia 
should be iodized to 40-50 ppm with potassium iodate (KI03). Indonesia has 
had a law mandating the fortification of salt with iodate since 1994; the lower 
limit has been set at 30 ppm I. Results of the national survey in 1996 (14) 
found that half of the salt consumed in 200,000 households was adequately 
iodized. 
Iodized injectable and orally administered oil in severely endemic areas. The 
iodized oil supplementation program has been operating since 1974. So far 
11 million people have received iodized oil injections. Starting from 1993, 
injected oil supplementation has been replaced by iodized oil through oral 
administration (12,53). 
The program of iodized oil has shown good results in many endemic areas 
and the approach of salt iodization, has shown progress in Indonesia. Administration 
of iodized oil by oral may become a more widely used method in the future. The 
major advantages of iodized oil administration are that it can be implemented 
immediately, and does not involve the complexities of altering salt production and 
trade. Thus, the usual places for iodized oil are for the areas of significant iodine 
deficiency where iodized salt is unlikely to be successfully implemented soon and 
correction is needed promptly. In many such areas, the iodized oil program will be 
necessary for at least several years, and for some remote areas it may be semi-
permanent (54). 
USE OF ORAL IODIZED OIL FOR CONTROLLING IODINE DEFICIENCY 
There is evidence from several studies in Algeria (55), Bolivia (56), Malawi 
(47) and Zaire (57), that oral administration of a single dose of iodized oil is effective 
for several years in protecting against iodine deficiency. Experience with oral iodized 
oil is more limited than that with the injected material, and precise guidelines for its 
optimal dose and duration of effectiveness are not available. 
21 
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At present it is suggested that a single oral dose of 1 ml_ (480 mg iodine) will 
provide adequate iodine for one to two years after administration. A previous study 
in Zaire suggests that smaller doses may be equally effective, at least for a year 
(57). A study by Furnee et al. (47) showed that a single dose of an iodized oil in 
which the iodized fatty acids from poppyseed oil are present as triacylglycerol esters 
(675 mg iodine) maintained urinary iodine concentration above 0.40 nmol/L for 
approximately one year whereas the duration of effectiveness of iodized oil (490 mg 
iodine) which consist of a mixture of ethyl esters of iodized fatty acids, lasted only 3-
4 months. While effectiveness is shorter than that of injection, oral administration 
avoids the need for syringes, needles, and sterile techniques, and can be 
administered by responsible persons without medical training. Capsules of iodized 
oil containing approximately 200 mg iodine are available and can be administered 
directly (58). 
Iodized oil is based on either triacylglycerol esters or ethyl esters of 
unsaturated fatty acids (59). When the unsaturated fatty acids react with potassium 
iodide, saturation of the double bound takes place with the addition of iodine to one 
of the carbon atoms involved (35). Up until now, the most widely available 
preparations have been based on poppyseed oil and have been manufactured by 
Guerbert Laboratories, France. Preparations containing triacylglycerol ester were 
marketed under the brand name of Oriodol® while those containing ethyl ester are 
marketed under the name of Lipiodol® UF. The fatty acid composition of poppyseed 
oil on a weight basis is: linolenic acid (C18:2, n-6), 73%; oleic acid (C18:1, n-9), 
14%; stearic acid (C18:0), 3%; and palmitic acid (C16:0), 9% (60). 
A Study by Van der Heide et al. (61) in both man and rats, showed that iodine 
was retained longer from a preparation prepared from ethyl oleate compared with a 
preparation prepared from ethyl linoleate or from ethyl esters derived from 
poppyseed oil. While the work described in this thesis was under way, Ingenbleek et 
al. (62) reported on the effectiveness of iodized rapeseed oil compared to iodized 
poppyseed oil. These authors found that iodized rapeseed supplying 752 mg I gave 
longer protection in moderate iodine deficient adults (30 wk) compared to iodized 
poppyseed supplying 729 mg (17 wk) when an iodine concentration in urine of 0.79 
iamol/L was taken as the cut-off point. Most of iodine in the rapeseed oil preparation 
was bound to oleic acid and in poppyseed oil preparation to linoleic acid (62). 
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Use of oral iodized oil in Indonesia 
The iodized oil capsule supplementation program started in Indonesia in 
1992/1993. The iodized oil supplement is distributed in moderate and severely 
endemic areas which were indicated by prevalence of total goiter rate 20-29% and 
30% and above respectively. The target group of this program is all males aged 0-20 
years and females aged 0-35 years, including pregnant and lactating women in 
moderate and severe endemic areas (63). In general, iodized oil should be avoided 
over the age of 45 years because of the possibility of precipitating hyperthyroidism 
(63). Pregnancy is not regarded as a contra-indication. It is desirable for the male 
population to be included in an iodized oil program even though the other groups 
already mentioned are more at risk. The experiences of males of the benefits will 
include greater productivity and quality of life which are important to community 
acceptance (63). 
An Indonesian pharmaceutical firm has introduced Yodiol® into the market. 
Yodiol® is prepared by iodization of peanut oil which has about three times more 
oleic acid and half the amount of linoleic acid compared with the established orally 
administered iodized oil which is prepared from poppyseed oil. Therefore, we 
decided to compare the efficacy of a preparation of iodized peanut oil with that of the 
iodized poppyseed oil preparation. 
OBJECTIVES AND HYPOTHESES OF THE STUDY 
The objectives and hypotheses (written in italics) of this study are as follows: 
Main objectives and hypotheses 
(1). To investigate and compare the efficacy of orally administered iodized peanut 
oil containing a high proportion of monounsaturated fatty acids and iodized 
poppyseed oil containing a high proportion of polyunsaturated fatty acids 
among Indonesian school children aged 8-10 years living in an endemic 
iodine deficient area. 
The efficacy of iodized peanut oil is higher than that of iodized poppyseed oil 
among Indonesian school children aged 8-10 years living in an endemic 
iodine deficient area. 
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(2). To evaluate different outcome indicators of IDD status: casual urinary iodine 
concentration, goiter size (measured by palpation and by ultrasound) and 
blood levels of FT4 and TSH at baseline and after oral iodized peanut oil 
supplementation in Indonesian school children aged 8-10 years living in an 
endemic iodine deficient area. 
Urinary iodine concentration, goiter size (measured by palpation and by 
ultrasound) and blood levels of FT4 and TSH at baseline and after oral iodized 
oil supplementation, indicated the same level of severity of iodine deficiency 
in Indonesian school children aged 8-10 years living in an endemic iodine 
deficient area. 
Secondary objectives and hypotheses 
(3). To investigate the effect of iodine supplementation on cognitive performance 
of Indonesian school children aged 8-10 years living in an endemic iodine 
deficient area. 
Iodine supplementation improves the cognitive performance of Indonesian 
school children aged 8-10 years living in an endemic iodine deficient area. 
(4). To investigate the relationship between nutritional status and cognitive 
performance of Indonesian school children aged 8-10 years living in an 
endemic iodine deficient area. 
School children living in an endemic iodine deficient area with adequate 
nutritional status, have better cognitive performance than malnourished 
school children. 
Tertiary objective and hypothesis 
(5). To investigate the relationship between iodized salt consumption and the 
iodine status of Indonesian school children aged 8-10 years living in an 
endemic iodine deficient area. 
Lower iodine intake from iodized salt is associated with lower status of iodine 
in Indonesian school children aged 8-10 years living in an endemic iodine 
deficient area. 
24 
General introduction 
OUTLINE OF THE THESIS 
The research described in this thesis was conducted between October 1996 
and December 1997 in an endemic iodine deficient area in Cilacap district, Central 
Java, Indonesia. 
Chapter 2 describes the efficacy of different oral preparations of iodized oil 
among school children living in an endemic iodine deficient area (Objective 1). 
Chapter 3 describes the comparison of indicators for measuring iodine status 
in population and the impact of iodized oil supplementation in school children living 
in an endemic iodine deficient area (Objective 2). 
Chapter 4 describes the effects of oral iodized oil and nutritional status on 
cognitive performance in school children living in an endemic iodine deficient area 
(Objectives 3, 4). 
Chapter 5 describes the impact of compulsory salt iodization on the iodine 
status of Indonesian school children living in an endemic iodine deficient area, as 
indicated by urinary iodine concentration, thyroid palpation and thyroid volume 
measured by ultrasound, and blood levels of FT4 and TSH (Objective 5). 
Chapter 6 discusses the most important findings of the research described in 
this thesis. 
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Efficacy of oral iodized peanut oil 
is greater than that of iodized poppyseed oil 
among Indonesian school children 
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ABSTRACT 
Oral iodized poppyseed oil is the major alternative to iodized salt for 
correcting iodine deficiency. There is a need for a more effective and cheaper 
iodized oil preparation. The aim of this study was to compare the efficacy of iodized 
peanut oil with that of iodized poppyseed oil. Randomly selected school children 
aged 8-10 y (n=251) in an endemic iodine deficient area in Indonesia were allocated 
to five groups and supplemented with a single oral dose of iodized peanut oil (200, 
400 or 800 mg I); iodized poppyseed oil (400 mg I); or peanut oil (placebo). Urinary 
iodine concentration was measured at 0, 4, 12, 25 and 50 wk. Except at baseline, 
urinary iodine concentration of all treatment groups was higher than in the placebo 
group. Urinary iodine concentration of the group supplemented with iodized peanut 
oil supplying 200 mg I was similar to the concentration of the group supplemented 
with iodized poppyseed oil. Comparing preparations supplying 400 mg I using a 
mathematical model, iodine retention from the peanut oil preparation was three 
times higher and the protection period twice as long as that of the poppyseed oil 
preparation. Reduction of thyroid volume in the iodized oil groups was greater than 
in the placebo group. There were no significant differences in serum thyroid 
stimulating hormone and serum free thyroxine among groups before or after 
treatment. Iodized peanut oil is more efficacious than iodized poppyseed oil 
containing the same amount of iodine in controlling iodine deficiency. 
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INTRODUCTION 
Effective control of iodine deficiency is still a challenge in developing 
countries (1). Despite the success of universal salt iodization (2,3), provision of 
iodized salt is sometimes ineffective because of economic conditions, a shortage of 
iodized salt in local markets, inadequately iodized salt, loss of iodine from salt 
because of excessive exposure to moisture, light and heat, and the use of non-
iodized local salt (4-6). Single intramuscular injections of iodized oil provide 
adequate iodine for two to three years (7) but injections have serious disadvantages, 
including the potential to serve as a vector for communicable diseases and the 
expense involved (8). Oral administration of iodized oil has been advocated as an 
alternative, but experience with this method is limited (9) and the optimal dose and 
the frequency of dosing remain uncertain (10). 
Until recently, the main raw material for iodized oil has been poppyseed oil. A 
study by Van der Heide et al. (11) indicated that iodine from iodized oil prepared 
from ethyl oleate was retained longer in both man and rats than that prepared from 
ethyl linoleate or ethyl esters of poppyseed oil fatty acids. Oils, such as peanut oil, 
which are rich in oleic acid, also have the advantage that they are cheaper as raw 
material than poppyseed oil. Therefore, we decided to compare the efficacy of a 
preparation of iodized peanut oil introduced onto the Indonesian market with that of 
the established iodized poppyseed oil preparation. While this work was under way, 
Ingenbleek et al. (12) reported on the efficacy of iodized rapeseed oil, the 
composition of which is not unlike that of iodized peanut oil. Preliminary results from 
the study presented in this paper have been published previously (13). 
SUBJECTS AND METHODS 
Subjects 
All school children (n=355) aged 8-10 y attending four primary schools in 
Cilacap district, Central Java Province, Indonesia, where goiter is highly prevalent 
(>30%) (14), were examined by a medical assistant from the Sub-district Health 
Center. Only apparently healthy subjects were considered for entry into the study. 
Study design 
This study was designed as a community based, double-blind, placebo-
controlled supplementation trial. A sample size of 50 per group was calculated with a 
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power index of 2.80, a=0.05 and p=0.20 to obtain a significant difference of 10% in 
urinary iodine concentration between groups with an expected drop out rate of 20%. 
From the eligible children (n=347), children were randomly selected and randomly 
allocated to one of 5 groups (50 per group), to receive one of the following 
preparations: 1 ml_ of peanut oil as placebo; 0.5 ml_, 1.0 ml_ and 2.0 ml_ of iodized 
peanut oil (Yodiol®, 400 mg l/mL, PT Kimia Farma, Indonesia), providing 200 mg, 
400 mg and 800 mg I respectively; or 1 ml_ of ethyl esters of iodized poppyseed oil 
(Lipiodol® UF, 400 mg l/mL, Guerbet Laboratory, France) providing 400 mg I. The 
placebo group was used to control whether the subjects were exposed to 
extraneous iodine during the study. The fatty acids composition of peanut oil 
compared with that of poppyseed oil is shown in Table 1. 
Table 1. Fatty-acid profiles of poppyseed and peanut oils. 
Saturated 
Palmitic acid (C16:0) 
Stearic acid (C18:0) 
Unsaturated 
Oleic acid (C18:1, n-9) 
Linoleicacid (C18:2, n-6) 
a-Linolenic acid (C18:3, n-3) 
Long chain fatty acids (C>20) 
Other 
Proportion of fatty 
Poppyseed oil1 
9.0 
3.0 
14.0 
73.0 
0.0 
0.0 
1.0 
acids, g/100g 
Peanut oil2 
14.6 
0.2 
41.1 
38.9 
1.5 
1.8 
1.9 
1
 Reference (15). 
2
 PT Kimia Farma, Indonesia. 
In a previous study by Furnee et al. (16), the retention of iodine from orally 
administered iodized oil was found to be reduced significantly by intestinal parasitic 
infestation. Therefore, one week prior to iodized oil administration, all subjects were 
dosed with the broad spectrum anti-helminth albendazole (400 mg per dose, 
SmithKline Beecham, Indonesia) to control Ascaris lumbricoides as it is known that 
these are endemic (17). 
The iodine status of the children was assessed by 4 different indicators, i.e.: 
thyroid volume, urinary iodine concentration, serum TSH and serum FT4 at baseline 
and 25 and 50 wk after supplementation. Additional measurements on urinary iodine 
concentration were done at 4 and 12 wk. 
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Methods 
Measurement of thyroid volume. Measurement of the thyroid volume using 
ultrasound was carried out by the main researcher (JU) who had been trained in the 
technique. The ultrasonography was performed on each subject in the sitting 
position using equipment with a transducer of 7.5 MHz (Phillips SDR 1480, 
Eindhoven, the Netherlands). The transducer was first kept horizontal at an upright 
angle to the neck to observe the cross section of the thyroid, measuring maximal 
width (w) and maximal depth (d). Next, the length (I) of each lobe was determined by 
longitudinal application of the transducer to the subject's neck. A co-worker recorded 
the observations of the ultrasonography and provided a continuous flow of persons 
to be examined. The volume was calculated using the following formula: V=0.479 x 
d x w x I (cm3) (18). The thyroid volume was the sum of the volumes of each lobe. 
Results of ultrasonography from the study population were compared to normative 
data from populations with sufficient iodine intake (19). 
Serum concentrations of thyroid stimulating hormone (TSH) and serum 
free thyroxine (FTJ. Venous blood samples (3 ml_) were drawn from an antecubical 
vein from non-fasting subjects between 08.30 and 12.00 using EDTA as anti 
coagulant. Immediately after collection, the blood was placed on ice, protected from 
light, and within 2-3 h, centrifuged at the laboratory of the district health center to 
obtain serum. Serum was frozen in a series of containers at -70 °C before being 
transferred, packed in dry ice, to the laboratory of Endocrinology, Academic Medical 
Center (Amsterdam, the Netherlands) for analysis. 
Serum concentration of TSH was measured by immunoluminometric assay 
using a commercial kit (Brahms Diagnostica Gmbh, Berlin, Germany) and FT4 was 
measured by time-resolved fluoro immunoassay after immuno-extraction using a 
commercial kit (Delfia™, Wallac Oy, Turku, Finland). The coefficient of variation of 
intra-assay and inter-assay for TSH were 2.4% and 4.5% respectively, and for FT4 
were 3.6% and 6.4% respectively. Values for both TSH and FT4 obtained were 
within 10% of the target value of normal and elevated samples provided every two 
months by the Dutch national external quality control scheme for hormones in serum 
(LWBA). Reference range of iodine replete subjects for serum TSH is 0.4-4.0 mU/L 
and for FT4 is 9-24 pmol/L (20). 
Urinary iodine concentration. A casual urine sample (5 ml_) was collected 
between 08.30 and 12.00 on 2 consecutive days at baseline and 4, 12, 25 and 50 
wk after treatment. The urine samples, preserved with approximately 1 g thymol, 
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were sent to the iodine laboratory of the Nutritional Research and Development 
Center in Bogor (Indonesia). Iodine concentration in urine was analyzed in duplicate 
after alkaline digestion using the Sandell-Kolthoff reaction (21), average values were 
calculated for each child. 
The model for describing urinary iodine concentration after oral dosing of 
iodized oil developed by Furnee et al. (10) was used. The model reflects the effects 
of iodine retention and elimination on urinary iodine concentration. 
Thus, lT=(a0+<x1)T"(V'V (equation 1), where: 
lT = Urinary iodine concentration at time T ((imol/L) 
cc0 = Iodine retention for placebo subjects (^mol/L) 
a, = Iodine retention for supplemented subjects (|amol/L) 
T = Time after dosing with iodized oil (wk) 
(30 = Rate of iodine elimination for placebo subjects (|imol/L/wk) 
p, = Rate of iodine elimination for supplemented subjects (|amol/L/wk) 
Statistical methods 
The Kolmogorov-Smirnov test was used to check the normality of data. Data 
are reported as mean and SD or SEM for normally distributed parameters and as 
median and 25th - 75th percentile for non-normally distributed parameters. 
Differences among groups were examined by analysis of variance (ANOVA) for 
normally distributed parameters and by the Kruskal-Wallis test for non-normally 
distributed parameters. If significant differences were indicated, comparisons among 
groups were made with the least significant difference test for normally distributed 
data and the Bonferroni's multiple comparison test at a significant level of P<0.01 for 
non-normally distributed data. 
The mathematical functions, transformed into log-linear equivalents, were 
fitted to the four values of urinary iodine concentrations in the four treatment groups. 
The parameters a, pand T were estimated using the maximum likelihood estimation 
technique (22) based on the average urinary iodine concentration measured in 
individuals on consecutive days. 
The SPSS software package (Windows version 7.5.3, SPSS Inc., Chicago, 
IL) was used for all statistical analyses and a P value<0.05 was considered 
significant. 
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Ethical Considerations 
The ethical guidelines of the Council for International Organizations of 
Medical Sciences (23) were followed. The Ethical Committee for Studies on Human 
Subjects, Faculty of Medicine, University of Indonesia approved the study. Informed 
consent was obtained from parents of each subject before the start of the study. 
Iodized oil was given at the end of the study to those children who were still 
considered iodine deficient. 
RESULTS 
Subject characterization 
There were no significant differences in age, thyroid volume, urinary iodine 
concentration, serum TSH and serum FT4 among the groups at baseline (Table 2). 
The children were, on average aged 9.45±0.76 y and moderately iodine deficient, 
with a median urinary iodine of 0.36 i^ mol/L (25th, 75th percentile; 0.27, 0.63 |amol/L). 
The prevalence of goiter was 24% (based on thyroid volume) and the median of 
thyroid volume of all children was 4.51 mL (25th, 75,h percentile; 3.96, 5.33 ml_). 
There were no statistical significant differences in thyroid volume, urinary iodine 
concentration, serum TSH and serum FT4 between boys and girls. 
Urinary iodine concentration 
Patterns of urinary iodine concentration after oral iodized oil supplementation 
in the different groups are shown in Figure 1. All treated groups had significantly 
higher urinary iodine concentration (P<0.001) at all periods of follow-up compared to 
the placebo group which received peanut oil. The higher the dosage of iodine in 
iodized peanut oil, the higher the urinary iodine concentration (P<0.001). Urinary 
iodine concentration of the group supplemented with iodized poppyseed oil 
supplying 400 mg I was similar of that of the group supplemented with iodized 
peanut oil supplying 200 mg I and significantly lower than that of other 
supplemented groups at all periods of follow up (P<0.001). 
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The regression model of urinary iodine concentration 
The efficacy coefficients of iodine retention, iodine elimination rate, and the 
protection period for different groups of treatment are shown in Table 3. The 
increases in iodine retention, elimination rate and protection period of the treatments 
were significantly different among the four groups (P<0.001) except the protection 
period for the iodized poppyseed oil supplying 400 mg I and iodized peanut oil 
supplying 200 mg I. Urinary iodine concentrations, as predicted by the regression 
model, after oral iodized oil supplementation for different groups of treatment are 
given in Figure 2. From week 4, iodine excretion declined exponentially. If an urinary 
iodine concentration of 0.79 i^mol/L is taken as the cut-off point, below which the 
recommended dietary allowance is not being met, then the protection period of 
iodized poppyseed oil supplying 400 mg I was about 42 wk, iodized peanut oil 
supplying 200 mg I, 400 mg I and 800 mg I were 49 wk, 77 wk and 124 wk 
respectively (Table 3). 
Table 3. Iodine retention, elimination and the model-based of protection period after oral 
administration of different iodized oil treatments for school children1 
Treatment Iodized Iodized peanut oil 
poppyseed 
oil, 400 mg I 200 mg I 400 mg I 800 mg I 
Iodine retention, 5.88 (1.16)a 8.59(1.15)b 17.55 (1.15)c 40.41(1.14)" 
a, (nmol/L) 
Iodine elimination 0.45 (0.05)a 0.53 (0.05)b 0.64 (0.05)c 0.75(0.05)" 
rate, p\ (nmol/L/wk) 
Protection period, 42.3 49.2 76.9 123.6 
T(wk)2 (33.8, 60.0)a (40.0, 69.2)a (62.1,112.7)" (96.0,171.7)° 
' See Equation 1 for method of calculation, values in parentheses are SE. 
2
 Time after dosing when the urinary iodine concentration remained above 0.79 (imol/L 
(100 ng/L) after correcting for changes in the urinary iodine concentration in the peanut 
oil (placebo) group, values in parentheses are 95% CI. Values within a row with different 
superscript letters are significantly different from one another using Bonferroni's multiple 
comparisons test. 
40 
Efficacy of oral iodized oil preparations 
1 
! 1 
_ 
e 
™ ™ ™ O 
? ? ? ? 
8 8 8 ? 
CO ^- OJ _ . 
o o 'o a> 'o 
3 3 3 >* 3 C C C S. C 
i • i . 
! ! ! ! 
i : i i 
i i i i 
t CM O CO 
*~ *- *- hi 
uoj}ej)uaouo 
i 
i 
t 
i 
r 
i 
to 
loiuri) 
/ if' 
/ r:" 
/ <:" 
/ /;ii / ' r / ' ••' 
1 ' i i 
/ i '• i 
/ ' • ' • 
/ ,'•''' 
/ * ;i -
/ / .'i ; 
/ 1 •! \ 
' i .1 i 
/ ;' i / :' ! 
' .'l :" 
/ ••' 1 
i :i ! 
' •' / / •' ' / .' i '. -
' i ' 
* i 
' i i 
'
%
 ' • i i 
i 
M- CM C 
3 sujpoj Ajeuun 
O 
i n 
o 
^ j -
o 
CO 
o 
CM 
. o 1_ 
Q 
) 
2? 
,5, 
9 
E 
H 
01 
- C 
>. 
. O 
T3 
CD 
JQ 
*v-
O (0 
CD 
13 
(0 
to 
c 
g 
§ c 
CD 
E 
<D 
a. 
Q . D 
CO 
"B 
(0 
CD 
E 
to 
0 
1 _ 
CD > 
>> 
C 
o 
to 
c 
0) 
o C a. 
o • 
" h-
0) ff 
• £ H 
TO — 
o . 
"
-
 c 
>. o 
« to 5 cr 
= 5 CD 
. c 
CM O 
2 "8 
3 £ a) oi 
u P 
41 
Chapter 2 
Goiter volume 
The goiter volumes measured by ultrasound for different groups of treatment 
are presented in Table 4. There were no significant differences in thyroid volumes 
among groups at baseline (P=0.085), but after supplementation there were 
significant differences in goiter volumes for all treated groups compared to the 
placebo group which received peanut oil. After a year of supplementation, reduction 
in goiter volumes were significantly higher in the supplemented groups compared to 
the placebo group at all period of follow up (P<0.001). There was no difference in 
the reduction of goiter volume among subjects supplemented with iodized peanut oil 
supplying 200 mg I or 400 mg I and those supplemented with iodized poppyseed oil 
supplying 400 mg I. 
Serum concentrations of TSH and FT4 
Initial median values of TSH were not different among the five groups and 
were within the normal range, but 2.8% of individuals had values above 5 mU/L. At 
50 wk after treatment, values of TSH remained within the normal range (median (25th 
- 75th percentiles); placebo, 1.60 (1.18-2.30) mU/L; iodized oil groups, 1.80 (1.30-
2.70) mU/L) and none had levels above 5 mU/L. Mean serum FT4 concentrations at 
baseline were in the normal range and were not different among the five groups. 
There was a small non-significant increase of serum FT4 concentrations at 25 wk 
among all groups including the placebo (mean ± SD; placebo, 17.32 ± 3.08 pmol/L; 
iodized oil groups, 17.98 ± 3.13 pmol/L), and values returned to baseline at 50 wk 
(mean ± SD; placebo, 16.74 ± 3.05 pmol/L; iodized oil groups, 16.97 ± 2.51 pmol/L). 
DISCUSSION 
This study shows that oral iodized oil is an effective alternative to salt 
iodization for the control of iodine deficiency. This study also found that the fatty 
acids composition of the iodized oil determines the efficacy of the treatment. Four 
outcome indicators were used to assess the efficacy of different oral iodized oil 
supplementation: urinary iodine concentration, thyroid volume, serum TSH and 
serum FT4 concentrations. 
Urinary iodine concentrations showed large variability and were very high in 
some subjects. Urinary iodine concentration was increased significantly among all 
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groups of treatments and placebo between 0 and 4 wk. The slight differences in 
urinary iodine concentration of the placebo group (P<0.05), could indicate that some 
children might have been exposed to an extraneous source of iodine, possible 
iodized salt (2,24). The urinary iodine concentration after supplementation of all 
groups of treatments at different periods of follow up (4, 12, 25 and 50 wk) were 
significantly higher than those of the placebo group. 
The efficacy of the iodized poppyseed oil preparation supplying 400 mg I as 
indicated by urinary iodine concentration, was similar to iodized peanut oil supplying 
200 mg I and significantly lower than iodized peanut oil supplying 400 or 800 mg I at 
all periods of follow up. Based on a mathematical model (10), comparing the iodized 
oil preparations supplying 400 mg I after adjustment for the increase of urinary 
iodine concentration in the placebo group, three times more iodine was retained 
from the iodized peanut oil preparation than from the iodized poppyseed oil 
preparation. In addition, iodized peanut oil gave a period of protection against iodine 
deficiency twice as long as that provided by iodized poppyseed oil (77 wk vs. 42 wk 
respectively). These findings confirmed the results from previous studies in rats and 
man (11), in which it was shown that iodine was retained longer from a preparation 
prepared from ethyl oleate compared with a preparation prepared from ethyl 
linoleate or from ethyl esters derived from poppyseed oil. 
A study by Ingenbleek et al. (12) on the effectiveness of iodized rapeseed oil 
appeared while this study was being carried out. These authors found that iodized 
rapeseed supplying 752 mg I gave a longer period of protection in moderate iodine 
deficient adults (30 wk) compared to iodized poppyseed supplying 729 mg (17 wk) 
when an iodine concentration in urine of 0.79 nmol/L was taken as the cut-off point. 
Most iodine in the rapeseed oil preparation was bound to oleic acid (52.5%) and in 
poppyseed oil preparation to linoleic acid (72.7%). Comparing iodized peanut oil with 
iodized poppyseed oil, the proportion of iodine derived from iodized oleic acid is 
higher (41 vs. 14%) and from linoleic acid is lower (39 vs. 73%) respectively. Our 
data show that iodized peanut oil supplying 400 mg I is estimated to have a 
protection period of about 77 wk, and iodized peanut oil supplying 800 mg I gives a 
protection period of 124 wk in moderate iodine deficient school children. Apart from 
the type of oil used and the location, our study differed in a sense that the subjects 
from Chad (12) were older (18-40 y) and were more iodine deficient than the 
children from our study. 
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Compared to the previous studies in school children (Table 5), our results 
showed that the same preparation of oral iodized poppyseed oil supplying 400 mg I, 
could protect school children from iodine deficiency for 42 wk, which was about twice 
as long as that of Benmiloud et al. (20) and three times longer than that was found 
by Furnee et al. (10) who used a cut-off point for urinary iodine concentration of 0.40 
lamol/L Differences in results among these studies might be due to the severity of 
iodine deficiency. The median urinary iodine concentration at baseline was 0.21 
nmol/L and 0.16 nmol/L in the study of Benmiloud et al. (20) and Furnee et al (10) 
respectively. Other possible factors are exposure to goitrogenic substances, 
nutritional status, the indicators employed and cut-off points used. 
We have also evidence that a high dose of 800 mg I is able to correct iodine 
deficiency, without any side-effects as found in the study by Elnagar et al. (25) in 
Sudan. They found that doses of 400 mg I and 800 mg I were slightly less effective 
than the 200 mg I and induced some adverse reactions, such as iodine induced 
inhibition of hormone synthesis (Wolff-Chaikoff effect). 
Thyroid volumes of the iodized oil supplemented groups were significantly 
lower than in the placebo group. Median thyroid volume decreased significantly in all 
groups, and the reduction of thyroid volume in all treatment groups was significantly 
higher than that in the placebo group. The reduction of thyroid volume in the placebo 
group might be due to introduction of iodized salt in the area during the study (24). 
The reduction of thyroid volume was positively correlated with the change of urinary 
iodine concentration among all groups (r=0.22). The thyroid volumes of previously 
iodine deficient children decreased to normal values in groups receiving either 
iodized poppyseed oil or iodized peanut oil, which suggest that the treatment of 
iodine deficient subjects using oral iodized oil effectively reduced goiter size. 
The efficacy of treatment indicated by the normalization of urinary iodine 
concentrations and thyroid volumes was not supported by changes in serum 
concentrations of TSH and FT4. Our results contrast with those reported by Eltom et 
al. (9), Elnagar et al. (25) and Tonglet et al. (26). They found that the efficacy of oral 
iodized oil supplementation could be demonstrated by normalization of serum T4 and 
TSH concentrations, reduction of goiter size measured by palpation or by an 
increase in urinary iodine concentration. Our data showed that median TSH 
concentrations were in the normal range before iodine treatment and only 2.8% 
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were higher than the upper normal limit. The responses of serum TSH were not 
correlated to the dose or type of iodized oil. The mean level of serum FT4 before 
iodine treatment was in the normal range, and slightly increased after iodine 
treatments, it did not differ significantly among the placebo and treatment groups. 
Our results concur with those of Gutekunst et al. (27) and Delange et al. (28) who 
observed no relationship between serum TSH and thyroid volume. Bourdoux (29) 
reported that the circulating levels of thyroid hormones and TSH in mild iodine 
deficient population, are not different from those observed in iodine-replete 
population. While in moderate iodine deficient population, with the prevalence of 
goiter ranging from 20 to 50%, it was observed that the levels of circulating T3 and T4 
were still in the normal range (29). The finding that urinary iodine concentration and 
thyroid volume of iodine deficient children became normal after supplementation, 
although serum TSH and serum FT4 concentrations did not show the same response 
to treatment, suggests that serum TSH and FT4 might be less reliable indicators for 
assessing and monitoring treatment of moderate iodine deficiency in school children 
than urinary iodine concentration or thyroid volume (30). 
We conclude that a single oral dose of iodized peanut oil compared to a 
single oral dose of iodized poppyseed oil results in three times higher iodine 
retention leading to a period of protection twice as long in iodine deficient school 
children. Thus iodized oil prepared from oleic acid rich oils, such as peanut oil and 
rapeseed oil should be given preference above preparation based on poppyseed oil 
in programs to control iodine deficiency. 
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through supplementation with iodized oil 
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ABSTRACT 
Sensitivity and specificity of indicators for assessing iodine status in 
populations and measuring the impact of programs aimed to reduce iodine 
deficiency are critical factors for selecting such indicators. The present study 
examined the relationship among primary indicators for assessing iodine deficiency 
and monitoring effectiveness of oral administration of iodized oil. Goiter prevalence 
by palpation, thyroid volume by ultrasound, urinary iodine concentration, serum 
concentrations of thyroid stimulating hormone (TSH) and free thyroxine (FT4) were 
measured in 186 school children in an endemic iodine deficient area in Indonesia, at 
baseline, 25 and 50 wk after oral administration of iodized oil. Serum thyroglobulin 
(Tg) concentration was assessed in a subsample of 40 school children at baseline. 
Goiter prevalence at baseline was 22% and 23% by palpation and ultrasound 
respectively, and the median urinary iodine concentration was 0.36 ^mol/L, 
suggesting that the area was moderately iodine deficient. However, the median of 
serum TSH and Tg concentrations and mean serum FT4 concentration at baseline 
were in the normal range. Thyroid volume was positively related to goiter assessed 
by palpation, however there was about 40% misclassification. After one year of 
treatment, thyroid volume and goiter prevalence were significantly reduced and 
urinary iodine concentration increased. Serum FT4 concentration increased within 
the normal range, but serum TSH concentration remained the same. Reduction of 
thyroid volume was associated with goiter grade at baseline and change in urinary 
iodine concentration. Urinary iodine concentration and thyroid volume are useful but 
serum concentrations of TSH and FT4 are not useful as indicators for assessing 
iodine status and measuring the impact of oral iodized oil supplementation among 
moderately iodine deficient school children. 
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INTRODUCTION 
In 1990 it was estimated that worldwide about 1600 million people were at 
risk of developing iodine deficiency disorders (IDD) (1). The prevalence and severity 
of iodine deficiency within a population, and the progress towards its elimination 
after intervention, can be assessed through various outcome indicators. The 
selection of an indicator is dependent on the acceptance of the indicator by the 
target population and field staff performing the assessment, on the ease of use in 
field conditions, and on the available resources in terms of money, laboratory 
equipment and staff (2). Another consideration for indicator selection is the 
performance in terms of sensitivity and specificity (3-6). A commonly used indicator 
is the prevalence of goiter as assessed through palpation. However, grading of 
goiter size by palpation has large intra and inter-observer variability. Therefore, in 
addition, other indicators of iodine or thyroid status are often used (7). 
WHO/UNICEF/ICCIDD (2) recommend the measurement of thyroid size using 
palpation and ultrasonography, the measurement of iodine concentration in urine 
and thyroid hormone concentrations (8). The use of single indicators, or 
combinations for studies or surveys, are not fully standardized but depend on study 
specific circumstances. So far the number of studies comparing the relative 
sensitivity and specificity between indicators in assessing iodine status of a 
population is limited and have given conflicting results (3-5,8). A similar lack of 
information exists for the assessment of the degree of change in iodine status after 
intervention such as salt iodization. For example, the prevalence of goiter in a 
population may remain unchanged after successful salt iodization whereas iodine 
concentration in the urine has increased (9). 
The aim of the present study was to compare iodine concentration in casual 
urine sample, goiter prevalence by palpation, thyroid size by ultrasound, and serum 
concentrations of free thyroxine (FTJ, thyroid stimulating hormone (TSH) and 
thyroglobulin (Tg) for the assessment of iodine status in a population of school 
children. Furthermore, changes in these indicators were compared after oral 
supplementation with iodized oil. 
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SUBJECTS AND METHODS 
Subjects 
Subjects were randomly selected from school children aged 8-10 years 
(n=186) attending four primary schools in Cilacap district, Central Java Province, 
Indonesia. This study was designed as a part of a community based, oral iodized oil 
supplementation trial. A sample size of 186 was calculated with a power of 0.8 for a 
significance level at 0.05 to obtain a significant difference of 11% between 
indicators. The study area was classified as a high-risk area for iodine deficiency, 
with an estimated total goiter rate of more than 30% (10). All subjects were 
examined by a medical assistant from the Sub-district Health Center, and only 
apparently healthy subjects were considered suitable for entry into the study. 
Study design 
At baseline the iodine status of subjects was assessed using five indicators: 
goiter grade measured by palpation, thyroid volume measured by ultrasonography, 
urinary iodine concentration, and serum concentrations of TSH and FT4 . After the 
baseline assessment all subjects were supplemented with an oral dose of iodized 
oil, which was large enough to cover iodine requirements for at least 49 wk. Details 
about the dose and type of iodized oil are presented elsewhere (11). Iodine status 
by all five indicators was again assessed at 25 wk and 50 wk after treatment with 
iodized oil. Additionally, measurement of urinary iodine concentration was done at 4 
and 12 wk. The concentration of serum Tg was measured in a subsample of 40 
children at baseline. 
Methods 
Measurement of thyroid size. Thyroid size was assessed using palpation 
and ultrasound techniques. Palpation of the thyroid was carried out by a district 
health worker who was experienced in the assessment according to WHO/UNICEF/ 
ICCIDD criteria (2). 
Measurement of the thyroid volume using ultrasound was carried out by the 
main researcher (JU) who had been trained in the technique. Ultrasonography was 
performed on each subject in the sitting position using equipment with a transducer 
of 7.5 MHz (Phillips SDR 1480, Eindhoven, the Netherlands). The transducer was 
first kept horizontal at an upright angle to the neck to observe the cross section of 
the thyroid, measuring maximal width (w) and maximal depth (d). Next, the length (I) 
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of each lobe was determined by longitudinal application of the transducer to the 
subject's neck. A co-worker recorded the observations of the ultrasonography and 
provided a continuous flow of persons to be examined. The volume was calculated 
using the following formula: V (cm3) =0.479 x d x w x I (6). The thyroid volume was 
the sum of the volumes of both lobes. Results of ultrasonography from the study 
population were compared to normative data from populations with sufficient iodine 
intake (12). 
Serum concentrations of thyroid stimulating hormone (TSH), free 
thyroxine (FTJ and thyroglobulin (Tg). Venous blood samples (3 mL) were drawn 
from an antecubical vein from non-fasting subjects between 08.30 and 12.00 using 
EDTA as anticoagulant. Immediately after collection, the blood was placed on ice, 
protected from light, and within 2-3 h, centrifuged at the laboratory of the district 
health center to obtain serum. Serum was frozen in a series of containers at -70 °C 
before being transferred, packed in dry ice, to the laboratory of Endocrinology, 
Academic Medical Center (Amsterdam, the Netherlands) for analysis. 
Serum concentration of TSH was measured by immuno luminometric assay 
using a commercial kit (ILMA; Brahms Diagnostica Gmbh, Berlin, Germany) and FT4 
by time-resolved fluoro immunoassay after immuno-extraction using a commercial kit 
(Delfia™, Wallac Oy, Turku, Finland). The coefficient of variation of intra-assay and 
inter-assay for TSH were 2.4% and 4.5% respectively, and for FT4 were 3.6% and 
6.4% respectively. Values for both TSH and FT4 obtained, were within 10% of the 
target value of normal and elevated samples provided every two months by the 
Dutch national external quality control scheme for hormones in serum (LWBA). 
Reference range of iodine replete subjects for serum TSH is 0.4-4.0 mU/L and for 
FT4is9-24pmol/L(13). 
The serum concentration of Tg was measured by ILMA using a commercial 
kit (Brahms Diagnostica Gmbh, Berlin, Germany). The method was standardized in 
house using serum differing four-fold in target concentrations. Intra-assay and inter-
assay coefficient of variation were 7-10% and 6-7% respectively depending on 
concentration. From a sample of 250 persons stratified by sex into five age groups 
from 20 to 70 y, the concentration of Tg varied from 1 to 45 pmol/L and values were 
not related to age and sex. Up until the present time, external quality control 
materials are still under development (14). 
Urinary iodine concentration. A casual urine sample (5 mL) was collected 
between 08.00 h and 12.00 h on 2 consecutive days at baseline and 4, 12, 25 and 
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50 wk after treatment. The urine samples, preserved with approximately 1 g thymol, 
were sent to the iodine laboratory of the Nutritional Research and Development 
Center in Bogor (Indonesia). Iodine concentration in urine was analyzed based on 
alkaline digestion using the Sandell-Kolthoff reaction (15). Urinary iodine level was 
measured in duplicate and the average calculated for each child. 
Statistical methods 
The Kolmogorov-Smirnov test was used to check whether the distribution of 
the variables was normal. Data are reported as mean and SD for normally 
distributed parameters and as median and 25th - 75th percentile for non-normally 
distributed parameters. Correlation between normally distributed parameters was 
measured by Pearson test and for non-normally distributed parameters by 
Spearman rank test. Differences between groups were examined by analysis of 
variance (ANOVA) for normally distributed parameters and by the Mann Whitney 
and Kruskal-Wallis test for non-normally distributed parameters. 
The software package of SPSS (windows version 7.5.2, SPSS Inc., Chicago, 
IL) was used for all statistical analyses and a P value<0.05 was considered 
significant. 
Ethical Considerations 
The guidelines of the Council for International Organizations of Medical 
Sciences (16) were followed. The ethical committee for studies on human subjects, 
Faculty of Medicine, University of Indonesia approved the study. Informed consent 
was obtained from parents of each subject before the start of the study. Iodized oil 
was given at the end of the study to those children who were still considered iodine 
deficient. 
RESULTS 
The average age of the subjects was 9.4 ± 0.8 y, and the sample included 84 
boys and 102 girls. The average body weight and height were 22.5 + 3.2 kg and 
121.1 ± 5.9 cm respectively. At baseline the prevalence of goiter as assessed by 
palpation was 21.5% whereas it was 22.6% as assessed by ultrasound. The median 
urinary iodine concentration of the population was 0.36 nmol/L, suggesting that the 
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subjects were moderately iodine deficient. However, the median serum 
concentration of TSH and mean serum concentration of FT4 at baseline were in 
normal ranges (Table 1). The median serum level of Tg in a subsample of 40 
children was 10.5 (6.0-17.5) pmol/L All but one value were in the normal range (1-
45 pmol/L). 
Table 1. Iodine status of the school children expressed by different indicators at different 
time periods during the study (n=186). 
Period 
Baseline 
25 wk 
50 wk 
P 
Thyroid volume1 
(mL) 
4.54 
(3.99-5.30) 
3.57 
(2.99-4.25) 
3.20 
(2.86-3.48) 
<0.0013 
Goiter by 
palpation 
(%) 
22 
20 
9 
<0.014 
Urinary iodine 
concentration1 
(nmol/L) 
0.36 
(0.29-0.65) 
1.98 
(1.20-3.51) 
1.12 
(0.84-1.90) 
<0.0013 
Serum thyroid 
stimulating 
hormone1 
(mU/L) 
1.8 
(1.2-2.5) 
1.7 
(1.1-2.2) 
1.8 
(1.3-2.7) 
NS 
Serum free 
thyroxine2 
(pmol/L) 
16.9+ 2.4 
17.9+ 3.1 
17.0+ 2.5 
<0.015 
1
 Median (25th - 75th percentile) 
2
 Mean ± SD 
3
 Kruskal-Wallis test 
4
 Spearman test 
5
 ANOVA 
The sensitivity and specificity of goiter measured by palpation against 
ultrasound were 57% and 89% at baseline, and 60% and 81% at 25 wk, while at 50 
wk of follow up, none of the school children had goiter as measured by ultrasound. 
There was a significant agreement (P<0.001) between goiter grades by palpation 
and thyroid volume measured by ultrasound at baseline and 25 wk (Table 2). The 
thyroid volume was significantly greater in subjects with goiter than in normal 
subjects, and it was also greater in subjects with grade 2 than with grade 1 goiter. 
There was no significant agreement between thyroid grades measured by palpation 
and thyroid volumes at 50 wk of follow-up (P =0.45). 
There was a significant reduction in thyroid volumes and in the prevalence of 
goiter measured by palpation at 50 wk after supplementation with oral iodized oil. 
The reduction in the goiter grade measured by palpation was significantly associated 
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with the reduction in thyroid volume, and the changes in thyroid volume were 
significantly greater for subjects who initially had goiter (P <0.001) (Table 2). Median 
urinary iodine concentration was significantly increased at 25 wk compared to 
baseline and reduced between 25 and 50 wk after supplementation. However all 
children maintained urinary iodine concentrations above 0.4 |amol/L (Table 2). A 
weak, but statistically significant, inverse correlation was found between the 
logarithm of urinary iodine concentration and thyroid volume at baseline (r=-0.15; 
P<0.05, Figure 1). Urinary iodine concentration was not related to any other 
indicators at baseline or any indicators at any periods of measurements (Table 3). 
There were no significant associations between goiter grades (palpation) and 
urinary iodine concentration, serum concentrations of TSH and FT4at baseline and 
at all periods of follow up (Table 2). Goiter grade (palpation) at baseline was also not 
related to serum Tg concentrations in a subsample of 40 children at baseline (data 
not shown). Subjects with a palpable goiter did not have lower urinary iodine, higher 
serum TSH, or lower serum FT4 concentrations than subjects without goiter at any 
time of measurement. 
Serum TSH and serum FT4 did not respond significantly to treatment with 
iodized oil. The mean of serum FT4 slightly increased at 25 wk in both goiter and 
normal groups, and went down to initial levels after 50 wk of treatment. The changes 
of FT4 were not significant and there was no difference between the normal and 
goiter groups (Table 2). A significant inverse correlation was found between the 
serum concentrations of TSH and of FT4 (r=-0.18; P<0.05, Figure 2) and a 
significant correlation was also found between the serum concentrations of TSH and 
of Tg in a subsample of the population (r=0.52; P <0.01). 
There were significant differences in the mean change of urinary iodine 
concentration between goitrous and normal subjects. Children who had goiter at 
baseline had greater iodine retention in their bodies at 4, 12 and 25 wk after 
treatment, compared to the non-goitrous children. At the 50th wk after intervention, 
both groups had a median urinary iodine within normal range and none of the 
children had goiter as measured by ultrasound (Table 4). 
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Thyroid volume (ml_) 
Figure 1. Linear logarithm relationship between thyroid volume and urinary 
iodine concentration (n=186; r=-0.15, P<0.05). The curved lines indicate the 
95% CI. 
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Figure 2. Relationship between thyroid stimulating hormone (TSH) and serum 
free thyroxine (n=186; r=-0.18, P<0.05). The curved lines indicate the 95% CI. 
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Table 4. Relationship between changes of urinary iodine concentration at different time 
periods and goiter measured by ultrasound before and after intervention 
Goiter (u 
Before 
Normal 
Goiter 
P 2 
trasound) 
End 
Normal 
Normal 
N 
144 
42 
Changes of urinary iodine concentration1 
4 wk 
4.98 
(2.40-9.61) 
8.48 
(3.53-13.94) 
<0.05 
12 wk 
3.01 
(1.55-6.27) 
5.11 
(1.95-8.86) 
<0.01 
25 wk 
1.37 
(0.73-2.60) 
2.01 
(0.79-3.69) 
<0.05 
50 wk 
0.83 
(0.39-1.33) 
0.78 
(0.47-1.46) 
NS 
1
 Median (25,h-75th percentile), urinary iodine concentration after treatment at baseline, 
|imol/L 
2
 Mann Whitney test 
DISCUSSION 
The results of this study illustrate some difficulties and inadequacies usually 
encountered in assessing iodine status of a population and monitoring the changes 
in status after intervention. The school children in this study had been judged as 
moderately iodine deficient at baseline. This judgment was based on the prevalence 
of goiter measured by palpation and ultrasound, at 21.5% and 22.6% respectively, 
and on a median urinary iodine concentration of 0.36 umol/L (2). However, the 
serum TSH, serum FT4 and serum Tg concentrations were in the normal range, 
suggesting that the population had adequately compensated for a low iodine intake. 
Measurement of thyroid size 
Surveys for currently assessing the prevalence of goiter mostly rely on thyroid 
palpation (7,17), and the presence of goiter is usually expressed according to the 
WHO classification (2). In populations suffering from moderate or severe iodine 
deficiency, especially among adults, thyroid palpation provides a reliable method for 
goiter assessment. However, the assessment becomes more problematic in areas 
with mild iodine deficiency especially when children are surveyed, because most 
iodine deficient subjects would, even in extreme cases, only have small goiters 
(4,18). 
Gutekunst and Martin-Teichert (19) showed that palpation often wrongly 
classifies thyroid size, when compared with ultrasound measurements. A study 
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among school children in northern and central Italy, found a discrepancy of more 
than 20% between thyroid palpation and ultrasound (4). The present study shows 
that about 43% of the children judged to have palpable goiter did not have goiter 
according to ultrasound measurements, and may therefore be wrongly classified. 
Gutekunst et al. (5,18) reported that among cases with palpable grade 1 goiter, an 
error rate as high as 30% might occur. Our study found that sensitivity and specificity 
of palpation against goiter measured by ultrasonography were 57% and 89% 
respectively at baseline, and the positive and negative predictive value was 60% 
and 88% respectively. These data show that palpation cannot provide an accurate 
assessment of the extent of iodine deficiency among children with mild to moderate 
iodine deficiency, since the sensitivity relative to ultrasonography is not very high. 
Thus, assessment of thyroid volume by ultrasound is preferable to thyroid palpation 
especially for monitoring the effectiveness of iodine deficiency control program 
(4,18,20,21). However, palpation still has a useful role in identifying those areas and 
populations with iodine deficiency (2). 
Urinary iodine concentration 
Urinary iodine concentration is widely recognized as a valid means for 
determining iodine intake in a population (3,17). Several approaches to classify the 
severity of iodine deficiency in a population have been proposed (2,22), the criteria 
used by WHO/ICCIDD/UNICEF (2), which are based on median urinary iodine 
concentration in casual samples, being used most commonly . The present study 
found that the urinary iodine concentration was not significantly associated with 
thyroid palpation grading. This might be due to the fact that all the school children 
had a deficient or marginally deficient status at baseline. Furthermore, iodine 
excretion is a marker for dietary iodine intake and reflects current iodine status (2), 
while goiter represents the integration of events extending over time, it is a historical 
relic that does not necessary indicate the present state of iodine nutrition (23). 
Therefore, individuals with goiter might have adequate urinary iodine status. 
Although there was no association between urinary iodine and goiter 
assessed by thyroid palpation, a significant inverse correlation was found between 
the logarithm of the urinary iodine concentration and thyroid volume, indicating that 
with higher urinary iodine concentrations, thyroid volumes were smaller. 
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Thyroid hormones 
Generally there was no relationship between serum TSH and FT4 and the 
other iodine status indicators. This finding corresponds with those reported by 
Delange et al. (24), Gutekunst et al. (5) and Pardede et al. (3) who also failed to 
observe a correlation between serum TSH and thyroid volume in children and adults. 
A rise in serum TSH is observed when iodine deficiency leads to chronic inadequate 
production of T4 and T3 in severe endemic areas (25). Studies have shown that the 
thyroids of iodine depleted rats are much more sensitive to TSH than those with 
normal urinary iodine concentrations (26). Gutekunst et al. (5) suggested that the 
reduced TSH level is a physiological response to protect the thyroid from additional 
growth and it is still discussed whether TSH is indeed a growth factor for the thyroid 
cell. In addition, the thyroid has an enormous capacity to store iodine and can buffer 
the hormone secretion rate. Thus serum TSH may not reflect recent dietary iodine 
as indicated by urinary iodine concentration. Indeed, in most endemic iodine 
deficient areas, measurement of serum TSH concentrations of subjects with goiter, 
have been well within normal limits (23). 
Our data show that serum concentrations of TSH, FT4 and Tg were in the 
normal range, although the prevalence of goiter was more than 20% and the median 
urinary iodine concentration less than 0.40 ^mol/L. A similar observation of normal 
levels of circulating T3, T4 and TSH was made in countries where the prevalence of 
goiter was 20 to 50%, and the urinary iodine concentration indicated mild iodine 
deficiency (22). 
Even though serum concentrations of TSH, FT4 and Tg were in the normal 
range, there was a significant inverse correlation between serum concentrations of 
FT4and of TSH at baseline (r=-0.18) and between serum concentration of TSH and 
of Tg in a subsample (r=0.52). This observation is probably related to the reported 
high turnover of the small iodine pool in the thyroid, which supposedly occurs in non-
adult subjects (22). 
Monitoring impact of interventions 
At 25 wk of follow up, the prevalence of goiter measured by ultrasound was 
reduced from 23% to 3%, while urinary iodine concentration increased from 0.36 
(imol/L to 1.98 nmol/L in which about 6% of the population had urinary iodine 
concentration less than 0.79 (imol/L. However, the prevalence of goiter measured by 
palpation only slightly reduced, from 22% to 20% at 25 wk of follow up, and the 
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serum TSH and FT4 concentrations both remained in the normal range. These data 
showed that both urinary iodine concentration and goiter measured by ultrasound 
indicated the same level of improvement on iodine status, but goiter measured by 
palpation, serum TSH and serum FT4 concentration indicated different levels of 
iodine status. 
After 50 wk of treatment with oral iodized oil, there was a significant reduction 
in thyroid volumes, prevalence of goiter and an increase in the median urinary iodine 
concentration. A significant increase in serum FT4 was also observed, even though 
both the initial and final level were within normal range. However, there was no 
significant change on the serum TSH concentration. This results suggest that in the 
population investigated, thyroid volume measured by ultrasound, thyroid palpation 
and urinary iodine concentration all gave a similar indication of the impact after 50 
wk of iodine supplementation, which was not so with serum TSH and FT4. This 
finding confirms the results of a previous study among iodine deficient school 
children in Algeria (13). 
The reduction of thyroid volumes at the 50 wk were significantly greater for 
children with higher grade of goiter at baseline and iodine was retained longer in the 
body until 25 wk for goitrous children compared to their non-goitrous counterpart. 
These results suggested that the efficacy of oral iodized oil supplementation was 
higher in subjects with more severe iodine deficiency, and there was agreement 
between the changes as indicated by the different indicators. 
We conclude that urinary iodine concentration and thyroid volume measured 
by ultrasound are the most useful epidemiological indicators for assessing iodine 
status and measuring the impact of iodized oil supplementation among moderately 
iodine deficient school children. These parameters found the same degree of iodine 
deficiency at baseline and after supplementation. The other indicators did not show 
concordant levels of iodine deficiency either at baseline or after treatment, 
suggesting that palpation, serum TSH, serum Tg and serum FT4 concentrations 
might be less reliable indicators for assessing and monitoring treatment in 
moderately iodine deficient school children than urinary iodine concentration or 
thyroid volume. Although these data highlight the limitations of thyroid palpation, this 
technique still has a useful place in assessing iodine status because no 
sophisticated equipment is required. However it is necessary for observers to be 
trained in the technique. 
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ABSTRACT 
Previous studies have shown that nutritional supplementation of 
undernourished children has a beneficial effect on their intellectual capacity. The aim 
of this study was to examine which factors were related to cognitive performance in 
children living in an iodine deficient area in Central Java, Indonesia. In addition, the 
effect of oral dosing with iodized oil was examined in a randomized placebo-
controlled trial in which cognitive performance was measured at baseline and 50 wk 
after treatment using Cattell's culturally fair intelligence test. Height, weight, thyroid 
volume, urinary iodine concentration, serum thyroid stimulating hormone and serum 
thyroxine were also measured at baseline and 50 wk after dosing. This work was 
part of a larger study examining the efficacy of iodized oil preparations in school 
children aged 8-10 years. Thus the placebo group (n=43) was compared with 121 
children receiving 200 mg, 400 mg or 800 mg of iodine from iodized peanut oil. 
The median cognitive performance at baseline was low (82; 25th-75th 
percentiles, 77-95) compared with the norm of 100, 32% of the children were 
underweight, 58% were stunted, 3% were wasted, and 40% were anemic. Multiple 
regression analysis showed that father's education and hemoglobin concentration 
were the main determinants of cognitive performance at baseline, and urinary iodine 
concentration and height for age Z-score were the most important determinants for 
improvement in cognitive performance after supplementation with iodized oil. 
Compared with the placebo group, there was a significant increase in urinary iodine 
concentration and reduction in thyroid volume but no change in the other parameters 
measured. 
We can conclude that cognitive performance after iodized oil supplementation 
did improve in those children who had at baseline low urinary iodine concentration or 
who were stunted. We also can conclude that anemia at baseline and father's 
education do play a role in cognitive performance. 
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INTRODUCTION 
There is a considerable body of evidence suggesting that iodine deficiency 
limiting mental development. Such evidence comes from ecological studies 
comparing children in iodine adequate and iodine deficient areas (1-4), case-control 
studies (5), studies in which mothers were treated with iodized oil (6) and 
comparisons of iodized oil dosed children with undosed children in another area 
(7,8). However, from such studies, it is not possible to determine whether iodine 
supplementation of iodine deficient children can stimulate their mental performance. 
When Bautista et al. (9) examined the effect of iodine supplementation on mental 
performance in a double-blind, placebo-controlled study, they found no difference 
between treated and untreated children based on the Stanford-Binet and Bender-
Gestalt tests. In a subsequent double-blind, placebo-controlled study group using a 
series of tests covering the full range of seven factors identified as primary mental 
abilities by Thurstone, Shresta et al. (10) showed that iodine supplementation 
increased IQ by about 10 points compared with the control group. 
Early studies suggested that the administration of oral iodized oil resulted in a 
significant reduction in the prevalence and size of goiter in the population (11-13). A 
controlled trial study with oral iodized oil in a small highland village in Bolivia, 
showed in the iodine supplementation study of Bautista et al. (9) mentioned above, 
that the decrease in goiter size was significantly associated with improvement in IQ 
score particularly in girls, even though correction of iodine deficiency did not 
increase mental performance. More data are required to show whether there would 
be a possible effect of oral iodized oil administration on the development of cognitive 
performance in iodine deficient school children. 
Underweight, stunting and iron deficiency are other risk factors for impaired 
cognitive performance (14-18). Populations at risk for iodine deficiency disorders 
(IDD) are also likely to have concurrent deficiencies of these risk factors. Physical 
growth retardation in infancy and early childhood are associated with poorer 
performance on cognitive tests (15,16,19,20). In addition, previous studies have 
shown that correcting nutritional anemia improves cognitive performance (21-23). 
The effect of supplementation with iodine and iron have been shown to be additive 
(10). 
This study aimed to investigate the association between stunting, anemia, 
iodine deficiency and cognitive performance among iodine deficient school children, 
and to measure the impact of iodine supplementation on cognitive performance. 
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SUBJECTS AND METHODS 
Subjects 
Subjects were randomly selected from school children aged 8-10 years 
(n=164) attending four primary schools in Cilacap district, Central Java Province, 
Indonesia, where goiter is highly prevalent (total goiter rate >30%) (24). All selected 
subjects were examined by a medical assistant from the sub-district health center, 
and only apparently healthy subjects were considered for entry into the study. 
Study design 
This study was in two phases: first, a cross-sectional phase and then a 
double-masked, placebo-controlled intervention phase. In the second phase, one 
group of children was given a single oral liquid dose of iodized peanut oil and a 
control group was given an oral dose of pure peanut oil in order to check whether 
the subjects were exposed to extraneous iodine during the study. A sample size of 
at least 36 subjects per group was calculated with a power index of 2.8, a=0.05 and 
P=0.20 which was regarded as sufficient to obtain a significant difference of 10% in 
cognitive performance between groups. This study was part of a larger study 
examining the efficacy of iodized oil preparations in school children aged 8-10 years. 
Thus the placebo group (n=43) was compared with 121 children receiving 200 mg 
(n=41), 400 mg (n=40) or 800 mg (n=40) of iodine from iodized peanut oil. The 
urinary iodine concentration and thyroid volume of all treatment groups were 
significantly improved after the supplementation, but there were no differences 
among the supplemented groups in cognitive performance. Therefore we combined 
the three iodized oil supplemented groups into one group. 
A previous study in Malawi showed that the duration of effectiveness of orally 
administered iodized oil was significantly reduced by intestinal parasitic infestation 
(25). Therefore, one week prior to administration of iodized oil, all subjects in this 
study, were dosed with the broad spectrum anti-helminth albendazole (400 mg per 
dose, SmithKline Beecham, Indonesia) to control Ascaris lumbricoides as it was 
known that these parasites are endemic in the study area (26). 
Methods 
Measurement of thyroid size. Thyroid size was measured at baseline and 
50 wk after treatment using ultrasound by the main researcher (JU) who had been 
trained in the technique. Ultrasonography was performed on each subject in the 
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sitting position. First, the transducer was kept horizontal at an upright angle to the 
neck to observe the cross section of the thyroid, measuring maximal width (w) and 
maximal thickness (d). Next, the length (I) of each lobe was determined by 
longitudinal application of the transducer to the subject's neck. A co-worker recorded 
the observations of the ultrasonography and provided a continuous flow of persons 
to be examined. The volume (V) was calculated using the following formula: V (cm3) 
=0.479 x d x w x I (27). The thyroid volume was the sum of the volumes of both 
lobes. Result of ultrasonography from the study population was compared to 
normative data from populations with sufficient iodine intake (28). 
Biochemical measurements. Venous blood samples (3 mL) were drawn 
from an antecubical vein from non-fasting subjects between 08.30 and 12.00 using 
EDTA as anticoagulant. Immediately after collection, the blood was placed on ice, 
protected from light and within 2-3 h centrifuged at the laboratory of the district 
health center to obtain serum. A sample of blood was taken for determination of the 
concentration of hemoglobin (only at baseline) using a HemoCue portable 
hemoglobinometer (29). Serum was frozen in a series of containers at -70 °C before 
being transferred, packed in dry ice, to the laboratory of Endocrinology, Academic 
Medical Center (Amsterdam, the Netherlands) for analysis. Serum levels of thyroid 
stimulating hormone (TSH) were measured by immunoluminometric assay 
techniques using a commercial kit (Brahms Diagnostica Gmbh, Berlin, Germany) 
and serum free thyroxine (FT4) was measured by time-resolved fluoro immunoassay 
after immuno-extraction using a commercial kit (Delfia™, Wallac Oy, Turku, Finland). 
The coefficient of variation of intra-assay and inter-assay for TSH were 2.4% and 
4.5% respectively, and for FT4 were 3.6% and 6.4% respectively. Values obtained 
for both TSH and FT4, were within 10% of the target value of normal and elevated 
samples provided every two months by the Dutch national external quality control 
scheme for hormones in serum (LWBA). The reference range of iodine replete 
subjects for serum TSH is 0.4-4.0 mU/L and for FT4, 9-24 pmol/L (13). 
A urine sample was collected between 08.00 h and 12.00 h on two 
consecutive days at baseline and at 50 wk after treatment. The samples, preserved 
with approximately 1 g thymol, were sent to the iodine laboratory of the Nutritional 
Research and Development Center in Bogor (Indonesia) for analysis. Iodine 
concentration in urine was analyzed based on alkaline digestion using the Sandell-
Kolthoff reaction (30) and was measured in duplicate and the average calculated for 
each child. 
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Assessment of cognitive performance. This was determined using 
Cattell's "Culture-Fair Intelligence Test" (CFIT) consisting of four subtests: series, 
classifications, matrices and conditions (topology) (31) at baseline and 50 wk after 
treatment by a team of district psychologists. This test is available in three levels: 
scale 1, for ages 4 to 8 y and mentally retarded adults; scale 2, for ages 8 to 13 and 
average adults; and scale 3, for grades 10 to 16 and superior adults. The CFIT scale 
2, which has been adapted to the Indonesian language, was used in this study. The 
average of cognitive scores considering as normal is 100 (range, 90-109) (31,32). 
Anthropometric measurements. The measurements were made in 
duplicate (33) by a trained assistant before and 50 wk after intervention. Height was 
measured to the nearest mm using a microtoise, weight to nearest 0.1 kg using an 
electronic scale, and mid-upper arm circumference (MUAC) to the nearest mm using 
a measuring tape. Results are expressed as the mean and, if two measurements 
differed by 2 mm for height ,0.1 kg for weight and by 1 mm for MUAC, they were 
repeated. Anthropometric indices were calculated using Epi Info ver. 6.0 software 
and the data were presented as Z-scores of weight-for-age (WAZ), height-for-age 
(HAZ), and weight-for-height (WHZ). These indices were compared to reference 
data of the National Center of Health Statistics (33) to judge whether the subjects 
were underweight, stunted or wasted respectively using a cut-off point of -2 SD. 
Statistical methods 
The Kolmogorov-Smirnov test was used to check the normality of data. Data 
are reported as mean and SD or SEM for normally distributed parameters and as 
median and 25,h - 75lh percentiles for non-normally distributed parameters. 
Differences between two groups were examined by student's t-test for normally 
distributed parameters or by the Mann Whitney test for non-normally distributed 
parameters. When more than two groups were compared, analysis of variance 
(ANOVA) for normally distributed data or the Kruskal-Wallis test for non-normally 
distributed data, were used to test whether there were significant differences. If 
significant differences were indicated, comparisons among groups were made with 
the least significant difference test for normally distributed data and the Bonferroni's 
multiple comparison test at a significant level of P<0.01 for non-normally distributed 
data. Correlation between continuous variables was determined by multiple 
regression analysis or Pearson test. The software package of Epi Info version 6 
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(CDC, Atlanta, GA) and SPSS Windows version 7.5.2 (SPSS Inc., Chicago, IL) was 
used for all statistical analyses, and a P value<0.05 was considered significant. 
Ethical Consideration 
The guidelines of the Council for International Organizations of Medical 
Sciences (34) were followed for ethical considerations. The ethical committee for 
studies on human subjects, Faculty of Medicine, University of Indonesia approved 
the study. Informed consent was obtained from parents of each subject before the 
start of the study. At the end of the study, iodized oil was given to those children who 
were still iodine deficient, and iron capsules were distributed to children who were 
anemic. 
RESULTS 
Subjects characteristics 
The mean height, weight and mid-upper arm circumference (MUAC) of the 
school children who participated in this study were 121.1 cm, 22.3 kg and 17.3 cm 
respectively. Overall 32% of the children were underweight, 58% stunted and 3% 
wasted. As the median urinary iodine concentration of the children was 0.36 (xmol/L 
the population was moderately iodine deficient, however the prevalence of goiter 
measured by ultrasonography was 35%, suggesting that the population was 
severely iodine deficient (35). Based on hemoglobin <110 g/L, 40% of the children 
were anemic. There were no significant differences in age, anthropometric status, 
hemoglobin concentration (Table 1) and iodine status (Table 2) at baseline between 
placebo and supplemented groups. 
Iodine status, anthropometric status and cognitive performance 
The median value of cognitive performance scores of the population studied 
was 84 (25,h-75lh percentiles; 77-95) and there was no difference between the 
placebo and supplemented group at baseline. After 50 wk supplementation with oral 
iodized peanut oil, there were significant increases in urinary iodine concentration 
and reduction in thyroid volume in the supplemented group compared to the control 
group. However, the serum TSH and serum FT4 concentrations did not respond to 
the treatment and remained in the normal range. Cognitive performance tended to 
increase but there was no significant difference between the increase in the 
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supplemented group and the placebo group (Table 2). There was a significant 
positive correlation between thyroid volume and stunting at all different periods of 
measurement: baseline (r=0.29, P<0.01); 25 wk (r=0.30, P<0.01) and 50 wk (r=0.30, 
P<0.01). 
Table 1. Baseline characteristics of the school children1 
Age (y) 
Males/females 
Hemoglobin concentration (g/L) 
Anemia (Hb <110 g/L; %) 
Height (cm) 
Weight (kg) 
Mid-upper arm circumference (cm) 
Stunting, HAZ<-2 (%) 
Underweight, WAZ<-2 (%) 
Wasting, WHZ<-2 (%) 
Peanut oil 
(Placebo) (n=43) 
9.2910.70 
15/28 
113.0±18.1 
36.4 
120.415.5 
22.413.3 
17.211.5 
62.8 
30.2 
0.0 
Iodized peanut oil 
(n=121) 
9.2710.70 
61/60 
114.4117.2 
48.4 
120.615.9 
22.3+3.1 
17.5+1.4 
55.4 
29.8 
3.4 
1
 Mean 1 SD 
Factors related to cognitive performance 
Urinary iodine concentration (P<0.05), hemoglobin status (P<0.05), father's 
education (P<0.01) and school performance (P<0.05) were associated with cognitive 
performance scores of the school children at baseline (Table 3). There was no 
significant difference in cognitive performance between boys and girls. However, 
multiple regression analysis between log transformed cognitive performance score 
at baseline and parameters which were related to cognitive performance in a 
univariate analysis showed that only hemoglobin concentration and father's 
education remained significant (P<0.05) (Table 4). 
Analysis of variance showed that changes in cognitive performance after 50 
wk of supplementation were significantly associated with urinary iodine 
concentration (P<0.01), HAZ (P<0.01) and school performance (P<0.05) at baseline, 
and the changes in cognitive performance were significantly different between the 
supplemented group and placebo group (Table 3). The same independent variables, 
examined using a multiple regression analysis with changes in cognitive 
performance over 50 wk as dependent variable, showed that urinary iodine 
concentration and HAZ at baseline were the only significant determinants (P<0.05). 
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Table 2. Iodine status, anthropometric status and cognitive performance at baseline and 50 
wk after supplementation among Indonesian school children aged 8-10 y1 
Urinary iodine 
concentration (umol/L) 
Thyroid volume (mL) 
Serum thyroid stimulating 
hormone concentration 
(mU/L) 
Serum free thyroxine 
concentration (pmol/L) 
Weight for age Z-score 
Height for age Z-score 
Cognitive performance 
scores 
Period 
Baseline 
50 wk 
Difference 
Baseline 
50 wk 
Difference 
Baseline 
50 wk 
Difference 
Baseline 
50 wk 
Difference 
Baseline 
50 wk 
Difference 
Baseline 
50 wk 
Difference 
Baseline 
50 wk 
Difference 
Peanut oil 
(Placebo) (n=43) 
0.38 (0.26-0.63) 
0.70(0.61-0.83) 
0.30(0.10-0.45) 
4.89±1.50 
4.73±1.43 
-0.17±0.18 
1.80(1.27-2.50) 
1.70(1.38-2.58) 
0.00 ((-0.50)-0.50) 
16.8±2.7 
16.8±3.3 
0.0±3.1 
-1.62±0.60 
-1.50±0.65 
0.02±0.22 
-2.14±0.73 
-1.87±0.76 
0.16±(-0.03) 
82 (74-98) 
88(81-103) 
4((-13)-6) 
iodized peanut oil 
(n=121) 
0.36(0.28-0.61) 
1.46 (0.95-1.94)t 
0.96 (0.50-1.50)t 
5.1411.32 
3.58±0.57 * 
-1.5711.20* 
1.70(1.10-2.40) 
1.80(1.30-2.70) 
0.10((-0.34)-0.80) 
16.912.1 
17.212.4 
0.412.4 
-1.60±0.72 
-1.52+0.71 
0.0010.23 
-2.12±0.88 
-1.88±0.84 
0.14±(-0.03) 
84 (80-93) 
89(81-95) 
2((-11)-8) 
Values are expressed as mean ± SD or median (25th, 75th percentiles). 
Differences between groups of normally distributed data using student t-test: *, P<0.01; 
differences between groups of non-normally distributed data using Mann-Whitney test: t , 
P<0.01 
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DISCUSSION 
The results indicate that iodine status and stunting are linked to changes in 
child cognitive performance after the children were supplemented with iodized oil. 
Iodized oil supplementation did not increase cognitive performance in the 
supplemented group as a whole. However subjects supplemented with iodized oil, 
who were iodine deficient at baseline, increased their cognitive performance more 
than those who were more iodine replete. A previous study in Indonesia showed that 
thyroid volume and urinary iodine concentration of iodine deficient school children 
were significantly related to cognitive performance (36). In a placebo-controlled 
study in Bolivia, Bautista et al. (9), showed that decrease in goiter size was 
significantly associated with improvement in IQ scores particularly in girls, but there 
was no difference in mental performance between supplemented and placebo 
groups. A study in Malawi showed that iodine supplementation increased IQ by 
about 10 points compared with the control group (10). 
The measurement of cognitive performance using Cattell's CFIT adapted to 
the Indonesian language, was used in this group of iodine deficient school children. 
The population studied had low scores of cognitive performance and suffered from a 
number of nutritional problems, including iodine deficiency, anemia and stunting. We 
found that cognitive performance was positively correlated with baseline values of 
urinary iodine concentration, hemoglobin concentration and father's education. 
However, multiple regression analysis indicated that hemoglobin concentration and 
father's education, both at baseline, were the most important determinants of 
cognitive performance. We did not find a positive correlation between the education 
of mothers and cognitive performance of school children, probably as the majority of 
the mothers (96%) had 6 years of education or less. The higher the education of 
father, the higher the cognitive scores and the higher the educational achievement 
of the school children as indicated by school grades. Intelligence is a complex 
variable and depends on many factors (37) including stimulation from the 
environment, such as education level of parents. 
There is much evidence that iron deficiency anemia impairs cognitive 
development (23,38-40). We found that 40% of the school children were anemic and 
the cognitive scores of the anemic children (Hb<110 g/L) were 3 points lower than 
their non-anemic counterparts. We suggest that anemia adversely affected the 
cognitive performance of these school children. Our findings are in line with the 
results of previous study in Malawi that showed iron supplementation resulted in 
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improvement of IQ by 3.7 points (10). 
Oral iodized oil supplementation resulted in an improvement of iodine status 
as indicated by an increase in urinary iodine concentration and decrease in thyroid 
volume. However, the iodine supplementation did not result in a larger improvement 
in cognitive performance scores compared to the placebo group, as the average 
cognitive performance score did not improve one year after treatment with oral 
iodized oil. Such a finding was also reported from a previous study in Spain (8) 
where supplementation with oral iodized oil did not improve mental and psychomotor 
performance of children from an iodine deficient area. 
Although there was no difference between the changes in cognitive scores of 
the iodine supplemented and placebo groups 50 wk after dosing, this is not 
necessarily inconsistent with previously reported effects of supplementation with 
iodized oil on cognitive performance. Firstly, since there was an inverse correlation 
between urinary iodine concentration at baseline and increase in cognitive score, 
this would suggest that iodine deficient children did benefit from iodine 
supplementation. In the study of Shresta et al. (10), the median urinary iodine 
concentration was 0.15 nmol/L compared with 0.36 |imol/L in our study population. 
Children with a baseline urinary iodine concentration <0.40 ^mol/L in the iodized oil 
supplemented group had greater changes in cognitive performance than their more 
iodine replete counterparts. Secondly, the strength of the relationship observed with 
baseline iodine status as measured by urinary iodine concentration is attenuated. 
Although urinary iodine concentration is a good indicator of iodine status at the 
group level, it is a poor indicator at the individual level because of the large intra-
individual variation in urinary iodine concentration (41,42). Thirdly, the effect 
observed had been attenuated by exposure of the population, both the iodized oil 
supplemented group and the placebo group, to iodine derived from iodized salt 
which has become increasingly available in the area during the study period (43). 
The significant reduction in thyroid volume in the supplemented group, was 
associated with a trend towards increased cognitive performance scores, but this did 
not reach statistical significance (P=0.42), possibly because of the reasons 
mentioned above in relation to urinary iodine concentration. Changes in serum 
concentrations of TSH and FT4 were not correlated with changes in cognitive 
performance. However, this would be expected as there was no change in the 
serum concentration of these hormones with iodine supplementation as discussed 
earlier (42). Pardede et al. (36) also found no relationship between cognitive 
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performance and serum TSH concentration in a cross-sectional study of school 
children in East Java. 
Stunting was also found to be related to increased cognitive performance in 
this study. There has been much debate about whether stunting is a harmless 
adaptation to poor dietary intakes or has a functional consequence (44). A study in 
Jamaica found that the deficit in mental development of stunted children was 
attributable to under-nutrition (15,45) and a previous study in Indonesia also showed 
a positive correlation between cognitive performance and HAZ among iodine 
deficient school children (36). In a study of children with endemic goiter in 
Northeastern Sicily, Vermiglio et al. (46) showed that children with cognitive 
deficiency had stunted growth and delayed skeletal maturity. Stunting may not 
directly cause poor intellectual development in children, but the same underlying 
factors that cause stunting such as socio-economic status of the family, may also 
impair children's intellectual growth (47). Most of the children in this study were from 
poor families, and their dietary intakes were below the recommended dietary 
intakes. 
In addition, normal linear growth is determined by variable contributions from 
genetic, nutritional and endocrine factors and continues until bone maturation in 
early adulthood. One of the major hormones that influence growth during childhood 
is triiodothyronine (48): before puberty, it may be the major determinant for normal 
maturation of bone (49). Untreated hypothyroidism in children results in profound 
growth retardation and delayed skeletal maturation. Linear growth is almost 
completely halted, but can be resumed quickly by replacement of thyroid hormones 
to produce a rapid catch-up period of growth (50). In this study we found a positive 
correlation between thyroid volume and stunting at all periods of measurement. 
We can conclude that cognitive performance after iodized oil supplementation 
did improve in those children who had at baseline low urinary iodine concentration or 
who were stunted. We also can conclude that anemia at baseline and father's 
education do play a role in cognitive performance. This illustrates the role of nutrition 
and social factors in cognitive development and performance in children. 
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ABSTRACT 
Objective: To evaluate the impact of the Indonesian salt iodization program on 
iodine status of school children living in an endemic iodine deficient area, as 
indicated by urinary iodine concentration, goiter size measured by palpation and 
ultrasound, serum thyroid stimulating hormone (TSH) concentration and serum free 
thyroxine (FT4) concentration. 
Design: A longitudinal prospective cohort study among Indonesian school children. 
Setting: Subjects living in an endemic iodine deficient area were enrolled voluntarily. 
Subjects: Fifty one apparently healthy school children aged 8-10 y in an iodine 
deficient area in Central Java, Indonesia, were recruited. 
Methods: Thyroid size measured by palpation and ultrasonography, urinary iodine 
concentration, serum TSH and serum FT4 concentrations were measured on three 
occasions at 0, 25 and 50 wk. At the same time periods, subjects were requested to 
bring salt samples that were used at their homes. 
Results: After one year of introduction on salt iodization, the proportion of 
household used adequately iodized salt increased significantly, from 2% to 54%, but 
there was inconsistency in using iodized salt within households during the study 
period. Median urinary iodine concentration of population studied improved from 
0.38 nmol/L to 0.70 (imol/L, but this level is still below 0.79 nmol/L which is regarded 
as adequate iodine status. Iodine status as indicated by urinary iodine concentration 
and thyroid volume, of children who consumed iodized salt was significantly higher 
than those consumed non-iodized salt. However, the prevalence of goiter, 
concentrations of serum FT4and serum TSH of children consuming iodized salt were 
not significantly different than those who consumed non-iodized salt. 
Conclusions: The impact of legislation requiring iodized salt for the Indonesian 
population is not successful although significant progress has been made in recent 
years. Consequently, iodine deficiency is still a serious public health problem in 
Indonesia and increased effort is needed to eradicate iodine deficiency. 
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INTRODUCTION 
The cause of iodine deficiency is mainly geological rather than social and 
economic. Iodine deficiency cannot be eliminated by changing dietary habits nor by 
eating specific kinds of foods grown in the same area. Therefore, correction of the 
deficiency has to be achieved by supplying iodine from an external source. This can 
be done in a number of ways including periodic supplementation of deficient 
populations with iodized oil capsules or other preparations, or by fortifying foods with 
iodine. The food most commonly chosen is salt. The iodization of salt is the 
approach most commonly proposed in order to provide a long term and sustainable 
solution as it is expected that this will enable iodine to reach the entire population (1-
3). A major international effort to implement the process has begun. Fortification of 
salt has been successful in eliminating iodine deficiencies in many countries (4). It 
was estimated that nearly 60 per cent of edible salt in the world is now iodized, and 
among those countries in the world with a recognized iodine deficiency problem, the 
majority has passed appropriate legislation to ensure universal salt iodization (4). 
However, data on the effectiveness of iodized salt for controlling iodine deficient 
population is still scanty. 
Indonesia has had a law mandating the fortification of salt with iodate (KI03) 
since 1994: the minimum level of fortification has been set at 30 mg l/kg. A recent 
study showed that about one half of the salt in the market in Indonesia was 
adequately iodized (5). Salt is iodized in more than 300 processing plants distributed 
over 24 provinces in the country, many of these are small and do not operate 
continuously (6), which might endanger a sustainable program of salt iodization. 
Considering a wide variation in salt iodine content at the national level, this 
study examines the impact of the introduction of salt iodization program on the 
iodine status of school children living in an iodine deficient area, as indicated by 
urinary iodine concentration, thyroid size measured by palpation and ultrasound, 
serum thyroid stimulating hormone (TSH) and serum free thyroxine (FTJ 
concentrations. 
SUBJECTS AND METHODS 
Subjects 
Subjects (n=51) were randomly selected from school children aged 8-10 
years attending four primary schools in Cilacap district, Central Java Province, 
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Indonesia, where goiter is highly prevalent (total goiter rate >30%) (7). All selected 
subjects were examined by a medical assistant from the Sub-district Health Center, 
and only apparently healthy subjects were considered for entry into the study. 
Study design 
This study was designed as a longitudinal study as part of a larger study on 
the efficacy of iodized oil (8). A sample size of at least 49, was calculated based on 
the possibility to estimate the prevalence of adequately iodized salt with a 
confidence level of 90% and a CI width of 10% using a design effect of 2 and an 
assumption that the prevalence would be about 10%. A total of 51 school children 
participated voluntarily in this study. Each of them was asked to submit samples of 
salt that were used in their home at three occasions, i.e.: 0, 25 and 50 wk. Urinary 
iodine concentration, thyroid size measured by palpation and ultrasound, serum TSH 
and FT4 concentrations were determined at the same period of salt samples 
collection. Anthropometric parameters were measured as described previously (9). 
Methods 
Measurement of thyroid size. Thyroid size was measured by palpation and 
ultrasound (10). Palpation of the thyroid was performed by one trained experienced 
medical officer at the Sub-district Health Center at 0, 25 and 50 wk. Measurement of 
thyroid volume using ultrasound was carried out at the same time as palpation by 
the main researcher (JU) who had been trained in the technique. Ultrasonography 
was performed on each subject in the sitting position. First, the transducer was kept 
horizontal at an upright angle to the neck to observe the cross section of the thyroid, 
measuring maximal width (w) and maximal depth (d). Next, the length (I) of each 
lobe was determined by longitudinal application of the transducer to the subject's 
neck. A co-worker recorded the observations of the ultrasonography and provided a 
continuous flow of persons to be examined. The volume was calculated using the 
following formula: V (cm3) =0.479 x d x w x I (11). The thyroid volume was the sum of 
the volumes of both lobes. Result of ultrasonography from the study population 
were compared to normative data from populations with sufficient iodine intake (12). 
Serum concentrations of TSH and FT4. Venous blood samples (3 ml_) were 
drawn from an antecubical vein from non-fasting subjects between 08.30 and 12.00 
using EDTA as anticoagulant. The blood was placed on ice, protected from light, 
and within 2-3 h centrifuged at the laboratory of the district health center to obtain 
90 
Salt iodization and iodine status 
serum. Serum was frozen in a series of containers at -70 °C before being 
transferred, packed in dry ice, to the laboratory of Endocrinology, Academic Medical 
Center (Amsterdam, the Netherlands) for analysis. 
The method used for measuring blood levels of the TSH was 
immunoluminometric assay techniques using a commercial kit (Brahms Diagnostica 
Gmbh, Berlin, Germany) and FT4 was measured by time-resolved fluoro 
immunoassay after immuno-extraction using a commercial kit (Delfia™, Wallac Oy, 
Turku, Finland). The coefficient of variation of intra-assay and inter-assay for TSH 
were 2.4% and 4.5% respectively, and for FT4 were 3.6% and 6.4% respectively. 
Values for both TSH and FT4 obtained, were within 10% of the target value of normal 
and elevated samples provided every two months by the Dutch national external 
quality control scheme for hormones in serum (LWBA). Reference range of iodine 
replete subjects for serum TSH is 0.4-4.0 mU/L and for FT4 is 9-24 pmol/L (13). 
Urinary iodine concentration. A casual urine sample (5 mL) was collected 
between 08.00 h and 12.00 h on 2 consecutive days at 0, 25 and 50 wk of study. 
The urine samples, preserved with approximately 1 g thymol, were sent to the iodine 
laboratory of the Nutritional Research and Development Center in Bogor 
(Indonesia). Iodine concentration in urine was analyzed, based on alkaline digestion 
using the Sandell-Kolthoff reaction (14), for duplicate and the average calculated 
from each child. 
Semi-quantitative salt iodine spot test. Children were requested to bring to 
school samples of salt used at their homes at 0, 25 and 50 wk. To limit any possible 
exchange of samples, each child was given a sealed plastic container with his name 
on it. A commercial spot test kit (Biofarma, Indonesia) was used for detecting the 
levels of potassium iodate (KI03) in salt samples. The test gave approximate 
concentration of the iodine content in salt. Using a color chart, the iodine levels in a 
salt sample were estimated (3). 
Statistical methods 
The normality of data was tested by the Kolmogorov-Smirnov test. Data are 
reported as mean and SD for normally distributed parameters and as median and 
25th - 75th percentile for non-normally distributed parameters. Differences among 
groups were examined by analysis of variance (ANOVA) for normally distributed 
parameters or by the Kruskal-Wallis for non-normally distributed parameters. If 
significant differences were indicated, comparisons among groups were made with 
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the least significant difference test for normally distributed data and the Bonferroni's 
multiple comparison test at a significant level of P<0.01 for non-normally distributed 
data. Correlation between continuous normally distributed variables was analyzed 
using Pearson test and for non-normally distributed variables by Spearman rank 
test. The software package of SPSS (Windows version 7.5.2, SPSS Inc., Chicago, 
IL) was used for all statistical analyses and a P value<0.05 was considered 
significant. 
Ethical Considerations 
The guidelines of the Council for International Organizations of Medical 
Sciences (15) were followed for ethical considerations. The Ethical Committee for 
Studies on Human Subjects, Faculty of Medicine, University of Indonesia approved 
the study. Informed consent was obtained from parents of each subject before the 
start of the study. 
RESULTS 
Subjects characteristics 
The subjects of this study were 20 boys and 31 girls with an average age of 
9.4±0.7 y, and the mean weight and height were 22.5±3.3 kg and 120.8±5.8 cm 
respectively. Overall 31.4% of the children were underweight (weight for age Z-
score<-2 SD), 58.8% stunted (height for age Z-score<-2 SD) and none was wasted 
(weight for height Z-score<-2 SD). 
Iodized salt in the households 
The proportion of adequately iodized salt increased significantly during one 
year of study (P<0.001). At the beginning of the study, about two years after salt 
legislation was promulgated, 2% of the samples were adequately iodized at more 
than 30 mg l/kg and 34% were not iodized at all. One year after the start of the 
study, 54% of the collected salt samples were adequately iodized and 11 % of the 
samples were not iodized (Table 1). However, inconsistency in using iodized salt 
was found within the households (Table 2). None of the subjects submitted 
adequately iodized salt at all three sampling periods during the study; only 14% 
twice submitted adequately iodized salt; and 35% of subjects never submitted 
adequately iodized salt. 
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Table 1. Number of household salt samples at 0, 25 and 50 wk containing different levels of 
iodine brought to school by 51 children in Cilacap, Central Java, Indonesia1 
Salt not iodized 
(0 mg l/kg) 
Salt not adequately iodized 
(<30 mg l/kg) 
Salt not iodized 
(>30 mg l/kg) 
Total 
0 
18(35%) 
32 (63%) 
1 (2%) 
51 
Time of salt collection 
25 
9(18%) 
23 (46%) 
18(36%) 
50 
(wk) 
50 
5 (10%) 
18(36%) 
27 (54%) 
50 
Spearman rank test, P<0.001, 
Iodine indicators and type of salt used in the households 
The prevalence of goiter measured by palpation remained at 17% at 50 wk. 
However, the prevalence of goiter measured by ultrasound was significantly reduced 
to 14% at 25 wk and 50 wk. Urinary iodine concentration of children studied was 
significantly increased at 25 wk, but serum TSH and serum FT4 concentrations 
remained in the normal range (Table 3). 
Children who brought salt which was adequately iodized, had a better iodine 
status than children who brought inadequately iodized salt (P<0.001). The higher the 
concentration of iodine in the salt the higher the urinary iodine concentration (Table 
4). Analysis of variance showed that children who consumed adequately iodized salt 
had smaller thyroid volumes (P<0.05) than those who consumed non-iodized salt. 
However, serum FT4 and TSH concentrations of school children consuming iodized 
salt were not significantly different to those who consumed non-iodized salt (Table 
3). 
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Table 3. Parameters of iodine status at 0, 25 and 50 wk in school children in Cilacap, 
Central Java, Indonesia1. 
Thyroid volume (mL) 
Prevalence of goiter (%) 
Palpation 
Ultrasound 
Urinary iodine 
concentration (umol/L) 
0 
(n=51) 
4.68±1.51 
17.7 
26.0 a 
0.38 (0.24-0.64) 
Time of salt collection 
25 
(n=50) 
4.48± 1.43 
16.7 
14.3b 
0.67(0.50-1.02)" 
(wk) 
50 
(n=50) 
4.54±1.45 
16.7 
14.3 b 
0.70 (0.61-0.83)d 
Serum thyroid stimulating 1.70 (1.20-2.30) 1.60 (0.96-2.20) 1.60 (1.18-2.30) 
hormone concentration 
(mU/L) 
Serum free thyroxine 16.74±2.66 17.3213.08 16.74±3.05 
concentration (pmol/L) 
1
 Values are presented as mean ± SD or median (25th - 75,h percentile). 
Correlation between non normally distributed variables were examined using Spearman 
rank test: values with different superscripts letters (a, b) are significantly different from one 
another (P<0.05). Differences among >2 groups were examined using Kruskal-Wallis test 
when not normally distributed and if significant (P<0.05) were tested using Bonferroni's post-
hoc multiple comparisons test: values of each parameter with different superscripts letters 
(c, d) are significantly different from one another (P<0.01). 
DISCUSSION 
This study indicates that salt iodization was significantly associated with 
improvement of urinary iodine status in Indonesian school children living in an 
endemic iodine deficient area. In rural areas of many developing countries, where 
iodine deficiency is most severe, populations are largely dependent on subsistence 
foods. Their diet is typically based on one or two cereals, tubers or pulses. If 
households have livestock, some dairy products are also consumed. Therefore, the 
only way for such people to obtain iodine is from outside sources such as iodized 
salt or iodized oil supplements. 
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Table 4. Relationships between parameters of iodine status in school children in Cilacap, 
Central Java, Indonesia and iodine content of salt samples which were pooled from three 
periods of collection (0, 25, 50 wk)1. 
Iodine content in salt (mg/kg) 
0 <30 >30 
(n=32) (n=73) (n=46) 
Thyroid volume (mL) 4.89±1.32a 4.65+1.55 a 4.21+1.35 b 
Urinary iodine 0.40 (0.27-0.69) 0.60 (0.37-0.77)c 0.71 (0.60-0.85)d 
concentration (umol/L) 
Serumthyroid 1.70(1.30-2.30) 1.60(1.00-2.00) 1.70(1.10-2.50) 
stimulating hormone 
concentration (mU/L) 
Serum free thyroxine 17.84+6.07 17.0812.96 16.97+2.76 
concentration (pmol/L) 
1
 Values are presented as meant SD or median (25,h - 75th percentile). 
Differences among >2 groups were examined using ANOVA test when normally distributed 
and if significant, were tested using least significant differences multiple comparisons test: 
values of each parameter with different superscripts letters (a, b) are significantly different 
from one another (P<0.05). Differences among >2 groups were examined using Kruskal-
Wallis test when not normally distributed and if significant were tested using Bonferroni's 
post-hoc multiple comparisons test: values of each parameter with different superscripts 
letters (c, d) are significantly different from one another (P<0.01). 
The first national IDD program in Indonesia, which began in 1974, provided 
iodized oil injections to people in endemic areas and began to iodize salt. UNICEF 
selected universal salt iodization as the means of reaching the goal of eliminating 
IDD. Progress towards this goal is determined by estimating the proportion of 
households with adequately iodized salt in countries affected by IDD (2). By the 
early 1990s, about half of Indonesia's salt was iodized. Indonesia introduced a law in 
1994, mandating the fortification of salt with iodate to the minimum level of 
fortification of 30 mg l/kg. The national program involves teachers and school 
children who learn about IDD and the use of iodized salt to avoid the problem (4). In 
1995, a national survey of iodized salt consumption in 220,000 households showed 
that half of them were using adequately iodized salt (>30 mg l/kg ), 28% 
inadequately iodized salt (<30 mg l/kg) and the rest non-iodized salt (5), which is in 
line with our results. Over a period of one year, the proportion of adequately iodized 
96 
Salt iodization and iodine status 
salt (>30 mg l/kg) in the area studied was significantly increased from 2% to 54%, 
the inadequately iodized salt (<30 mg l/kg) was proportionally reduced from 63% to 
36% and non-iodized salt was reduced from 35% to 10%. 
Our data suggests that there was progress in increasing the proportion of 
iodized salt used in the area studied, although about 45% salt used in the 
households was not adequately iodized or not iodized at all. However, households 
were not consistent in their use of iodized salt during the one year study period. In 
addition, none of subjects studied used adequately iodized salt at all time periods 
and 35% of the subjects never brought adequately iodized salt from their homes. 
Our findings indicate that there was still a low awareness of the population at risk of 
the need to use adequately iodized salt. Cheaper non-iodized salt was found to be 
available in the market in the area studied and this subverted the effectiveness of 
the iodized salt program. This study underlines the importance of monitoring the salt 
iodization program as well as of educating the population on the importance of 
iodized salt. 
In the Tiberina valley, in Italy, Aghini et al. (16) found that iodized salt 
prophylaxis was able to prevent the development of goiter in children born after the 
implementation of iodized salt consumption, and to control thyroid enlargement in 
older children. However, it was less effective in reducing the size of goiter in children 
exposed to iodine deficiency in the first years of life and later given access to iodized 
salt. In our study, one year after the introduction of salt iodization, urinary iodine 
concentration had increased from a median level at 0 wk of 0.38 fxmol/L to 0.70 |imol 
/L, and prevalence of goiter measured by ultrasound decreased from 26% to 14%. 
Prevalence of goiter measured by palpation remained at 17%, but this could be 
attributed to misclassification in goiter measured by palpation compared to when 
measured by ultrasound (17). In addition palpation might not be sufficiently 
sensitive to detect small reduction in thyroid volume. 
We found that children who consumed iodized salt had higher concentrations 
of urinary iodine and smaller thyroid volumes than those who did not. However, we 
did not find significant differences in serum FT4 and serum TSH among children 
consuming salt that was iodized at different levels. These results are in line with 
those reported earlier with iodized oil (8,17). We have also shown that serum 
concentrations of FT4 and TSH in children do not respond to dosing with iodized oil 
(17). It is also unlikely that the concentrations of other hormones in serum would be 
useful for monitoring changes in iodine status brought about either by the use of oral 
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iodized oil or iodized salt. For example, thyroglobulin concentration did not correlate 
in this population with urinary iodine concentration (17) and in addition, there are no 
international standard for its measurement (18). Serum FT4 and TSH levels were 
initially and remained in the normal range after supplementation with iodized oil 
although urinary iodine concentration and thyroid volume did respond to dosing (17). 
Our finding indicated that salt iodization is not simply a matter of passing 
legislation. Provision of iodized salt is sometimes ineffective because of economic 
conditions, a shortage of iodized salt in local markets, inadequately iodized salt, loss 
of iodine from salt because of excessive exposure to moisture, light and heat, and 
the use of non-iodized local salt (19-21). In addition, cooking practices of the 
population might influence the availability of iodine supplied by iodized salt. A study 
on the effect of Indonesian cooking practices on stability of iodized salt showed that 
some spices such as chili and acids might cause losses of iodine (22). 
The hot Indonesian climate increases salt requirements and rice-eating 
populations also consume more salt than others because rice itself contain very little 
in salt (23). Legislation in Indonesia, requires salt to contain at least 30 mg l/kg. To 
counteract this iodine deficiency, a salt intake of 4-5 g per person per day is 
necessary to provide the iodine requirement of 120 jig for children aged 8-10 y. 
However little information is available on the intake of salt in Indonesia. It is 
assumed that per caput consumption is about 10 g/d of which 50% is discretionary. 
A study of salt intake using a lithium-labeled salt, showed that the average daily salt 
consumption in rural Guatemalan boys was 1.8± 0.6 g and Beninese boys 5.7 ± 2.8 
g, of which 72 ± 12% and 50 ± 13% respectively came from discretionary sources 
(24). More information is required on average salt consumption in Indonesia. 
It is concluded from the present study that the impact of legislation requiring 
iodized salt for the Indonesian population has not been successful although 
significant progress has been made in recent years. Consequently, iodine deficiency 
is still a serious public health problem in Indonesia and increased effort is needed to 
eradicate iodine deficiency. 
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CONTROLLING IODINE DEFICIENCY 
Iodized salt or iodized oil? 
Universal salt iodization and iodized oil supplementation can both be used to 
control iodine deficiency. Universal salt iodization is the main strategy adopted 
worldwide for elimination of iodine deficiency disorders (IDD) (1). Although iodization 
of salt has been successful in many countries in reducing the prevalence of IDD, 
additional strategies are required to eradicate IDD for the coming decades because 
not all communities at-risk of IDD consume iodized salt yet. 
Supplementation with oral iodized oil has shown good results in many 
endemic areas and may become a more widely used method. The major 
advantages of iodized oil administration are that it can be implemented quickly, has 
immediate impact, and does not involve the complexities of altering salt production 
and trade. Iodized oil has a role in areas of significant iodine deficiency where salt 
iodization is unlikely to be successfully implemented soon and correction is needed 
promptly. In many such areas, an iodized oil program will be necessary for at least 
several years, and for some remote areas it may be semi-permanent (2). At present, 
most countries depend on an oral iodized poppyseed oil preparation, which is made 
from a raw material derived from the opium poppy {Papaver somniferum). Since 
cultivation of this plant is tightly regulated, iodized oil has become relatively 
expensive (3). There is an urgent need to increase the production of iodized oil and 
to make available an alternative product which is cheaper and effective (4). 
Which iodized oil? 
Studies in rats and man by Van der Heide et al. (5) indicated that iodine from 
a preparation based on ethyl oleate was retained longer in the body than a 
preparation based on ethyl linoleate or from ethyl esters derived from poppyseed oil. 
A report of a study by Ingenbleek et al. (3) on the effectiveness of iodized rapeseed 
oil appeared while this study was being carried out. These authors reported that 
iodized rapeseed oil supplying 752 mg I gave a longer period of protection in 
moderate iodine deficient adults (30 wk) compared to iodized poppyseed oil 
supplying 729 mg I (17 wk) when an iodine concentration in urine of 0.79 |amol/L 
was taken as the cut-off point. Most of iodine in the rapeseed oil preparation was 
bound to oleic acid whereas in the poppyseed oil preparation the iodine is bound to 
linoleic acid. 
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In our study (Chapter 2) we compared iodized peanut oil with iodized 
poppyseed oil. Peanut oil contains three times more oleic acid and one half of the 
amount of linoleic acid than poppyseed oil. The duration of effectiveness of a single 
oral dose of iodized peanut oil was about twice that of the iodized poppyseed oil (77 
wk vs 42 wk; both preparations contained 400 mg I) in moderate iodine deficient 
school children. Thus we have been able to confirm the results obtained by 
Ingenbleek et al. (3), with another iodized oil also based on an oleic acid rich oil and 
in another population and setting. Therefore, iodized oils prepared from peanut oil 
and rapeseed oil should be preferred above those from poppyseed oil in programs 
to control iodine deficiency. 
Efficacy of oral iodized peanut oil 
Although experience in using oral iodized oil is limited, previous studies in 
Algeria (6), Bolivia (7), Malawi (8,9) and Zaire (10) have demonstrated that a single 
oral dose of iodized oil can meet iodine requirements for one or two years. The study 
in Algeria by Benmiloud et al. (6) showed that a single oral dose of iodized 
poppyseed oil providing 240 mg I effectively protected iodine deficiency in children 
aged 6-11 y for 6 months and a dose of 480 mg I for 12 months. Furnee et al. (9) 
found that 1 ml_ of oral iodized poppyseed (490 mg I, ethyl esters of iodized fatty 
acids) effectively protected school children from moderately iodine deficiency (cut-off 
point 0.4 |imol/L) for 13.7 wk. Our results showed that the same preparation of oral 
iodized poppyseed oil supplying 400 mg I, could provide school children with enough 
iodine for 42 wk, which was about twice as long as that reported by Benmiloud et al. 
(6) and much longer than that found by Furnee et al. (9) who used a cut-off points of 
urinary iodine concentration half that used by Benmiloud et al (6) and by us. Our 
results are different from those reported previously probably because of the severity 
of iodine deficiency. Other factors include, external iodine intake, possible exposure 
to goitrogenic substances, nutritional status with respect to other nutrients, and the 
indicators and cut-off points used. Our data indicate that iodized peanut oil is 
efficacious for controlling iodine deficiency: a single dose 200 mg I effectively 
protected iodine deficient school children who have limited access to iodized salt for 
one year (Chapter 2). 
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ASSESSMENT OF IODINE DEFICIENCY AND MEASURING ITS IMPROVEMENT 
The status of iodine deficiency in a population, and the progress towards its 
elimination after intervention, can be assessed through various outcome indicators. 
The choice of a single indicator, or a combination of indicators for studies or surveys, 
is not fully standardized but rather depends on the specific circumstances of the 
study. So far, the number of studies comparing the relative sensitivity and specificity 
between indicators in assessing iodine status of a population is limited and have 
given conflicting results (11-18). 
The school children in the present study were judged to be moderately iodine 
deficient at baseline as indicated by a prevalence of goiter measured by palpation 
and ultrasound, at 22% and 23% respectively, and a median urinary iodine 
concentration of 0.36 nmol/L (19). However, serum TSH and serum FT4 
concentrations were in the normal range, suggesting that the population had an 
adequate iodine status. One year after treatment with oral iodized peanut oil, there 
were significant reductions in thyroid volume and prevalence of goiter and an 
increase in the median urinary iodine concentration of the population. A significant 
increase of serum FT4 concentration was also observed half a year after 
supplementation, but both the initial and final levels were within the normal range. 
There was no significant change in the serum TSH concentration. The results 
suggest that thyroid volume measured by ultrasound and by palpation and urinary 
iodine concentration gave similar information on the severity of iodine deficiency and 
all indicated an improvement in iodine status after treatment with oral iodized oil. 
Serum TSH and FT4 concentrations did not give any indications of iodine deficiency. 
Although the prevalence indicated agreement, the sensitivity and specificity of 
palpation evaluated against goiter measured by ultrasonography were 55% and 90% 
respectively at baseline. The positive and negative predictive values were 60% and 
88% respectively. These data show that palpation is of limited value for use in 
surveys of school children to identify communities suffering from iodine deficiency 
and to identify changes in iodine status. Such a conclusion has been drawn by 
others previously (13,16,20,21). Although these data highlight the limitation of 
thyroid palpation, this method still has a useful place in assessing whether or not a 
problem of iodine deficiency exist because no sophisticated equipment is required. 
However it is necessary for observers to be trained adequately in the technique. 
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Based on our studies, urinary iodine concentration and thyroid volume are the 
best indicators for assessing iodine status and measuring the impact of iodized oil 
supplementation among iodine deficient school children (Chapter 3). 
EFFECT OF STUNTING, IODINE DEFICIENCY AND ORAL IODIZED OIL ON 
COGNITIVE PERFORMANCE 
We found that the population studied had a low score for cognitive 
performance and suffered from multiple nutritional deficiencies: iodine deficiency, 
iron deficiency anemia and stunting. Earlier studies have shown that some 
improvement in cognitive performance can be achieved by appropriate 
supplementation (22-27). Our results showed that both nutritional and non nutritional 
factors played a role in cognitive performance of the school children. Father's 
education and hemoglobin concentration were the main determinants of cognitive 
performance at baseline, and urinary iodine concentration and stunting were the 
most important determinants for improvement in cognitive performance after 
supplementation with iodized oil. We did not find a positive correlation between the 
education of mothers and cognitive performance of school children, probably as the 
majority of the mothers (96%) had 6 years of education or less. The higher the 
education of father, the higher the cognitive scores and the higher the educational 
achievement of the school children as indicated by school grades. 
There has been much debate about whether stunting is a harmless 
adaptation to poor dietary intakes or has a functional consequence (28). This study 
confirmed results of previous studies (11,24,29,30) that stunting has a role in 
cognitive development. Stunting may not directly cause poor intellectual 
development in children, but the same underlying factors that cause stunting such 
as socio-economic status of the family, may also impair children's intellectual growth 
(1). Most of the children in this study were from poor families, and their diets were 
below the recommended dietary intakes. In addition, we found a positive correlation 
between thyroid volume and stunting at all periods of measurement. Normal linear 
growth is determined by variable contributions from genetic, nutritional and 
endocrine factors and continues until bone maturation in early adulthood. One of the 
major hormones that influence growth during childhood is triiodothyronine (31): 
before puberty, it may be the major determinant for normal maturation of bone (32). 
Untreated hypothyroidism in children results in profound growth retardation and 
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delayed skeletal maturation. Linear growth is almost completely halted, but can be 
resumed quickly by replacement of thyroid hormones to produce a rapid catch-up 
period of growth (33). 
We found that 40% of the school children were anemic and the cognitive 
scores of the anemic children (hemoglobin <110 g/L) were 3 points lower than their 
non-anemic counterparts. Our findings are in line with those earlier studies that 
showed iron deficiency anemia impairs cognitive development (22,23). 
Previous studies in iodine deficient school children have shown impairment of 
school performance and IQ when compared to similar groups from iodine-replete 
areas (7). Iodine deficiency results in a shift of the distribution of cognitive skills of 
the entire population to a lower level. In iodine deficient populations, mild mental 
impairment has been shown to occur five times more frequently than in populations 
with normal iodine status (34) and that the IQ curve of the population can be shifted 
10 points to the left (35). Although a single oral dose of iodized oil improved iodine 
status of our population, it did not result in improvement of cognitive performance 
compared to the placebo group. However, the changes in cognitive score were 
inversely correlated to the urinary iodine concentration which indicates that iodine 
deficient children did benefit more in cognitive performance from iodine 
supplementation than their more replete counterparts. This supports earlier findings 
that iodine supplementation can increase cognitive performance of school children 
(22). 
This study suggest that iodine status as measured by urinary iodine 
concentration at baseline and stunting are related to the improvement of cognitive 
performance when children are dosed with iodized oil. In addition anemia and 
father's education play a role in cognition. This illustrates the role of nutrition and 
social factors in cognitive development and performance in children (Chapter 4). 
IODIZED SALT FOR CONTROLLING IODINE DEFICIENCY 
Universal salt iodization is the major public health nutrition measure for 
eliminating iodine deficiency on a long-term basis (36). Many countries have already 
made significant progress towards the elimination of IDD, largely as a result of salt 
iodization (37). In rural areas of many developing countries, where iodine deficiency 
is often most severe, populations are largely dependent on subsistence foods. 
Therefore, the main or only source of iodine in this kind of area is iodized salt or 
106 
General discussion 
supplementation with iodized oil. Although, it is well established that an adequate 
iodine intake prevents iodine deficiency disorders, data on the effectiveness of 
iodized salt for controlling iodine deficiency are still scanty. 
During the one year of the study when there was increasing access to iodized 
salt, the proportion of adequately iodized salt used by households increased from 
2% to 54%. However, households were nor consistent in their usage of iodized salt 
throughout the year, and the majority also used not-adequately iodized salt at least 
once. The median value of urinary iodine concentration of the school children 
improved from 0.38 (imol/L to 0.70 |amol/L and prevalence of goiter measured by 
ultrasound decreased from 26% to 14%. Prevalence of goiter measured by palpation 
remained at 17%, but this could be attributed to misclassification in goiter measured 
by palpation compared to when measured by ultrasound (Chapter 3), and palpation 
might not be sufficiently sensitive to detect small changes in thyroid volume. In 
addition, there were no significant differences in serum concentrations of TSH and 
FT4 among children consuming salt that was iodized at different levels. These results 
confirm those described above on the use of thyroid palpation and serum 
concentrations of TSH and FT4 for assessing the impact of iodine prophylaxis but 
with iodized oil (Chapter 2; Chapter 3). 
Household use of iodized salt was related significantly to urinary iodine 
concentration and thyroid volume (Chapter 5). Although the use of iodized salt in 
households increased, about half of the salt available in the market was still not 
adequately iodized or iodized at all. The availability of cheaper non-iodized salt in 
the market, subverted the effectiveness of the iodized salt program. These findings 
indicate that iodine prophylaxis using iodized salt is not simply a matter of passing 
legislation, but should also include advocacy, education, marketing, an overall 
system of quality assurance and monitoring of the salt iodization program. 
CONCLUSIONS 
• A single oral dose of iodized peanut oil compared to a single oral dose of iodized 
poppyseed oil resulted in three times higher iodine retention leading to a period 
of protection twice as long in iodine deficient school children. Peanut oil is 
characterized by having a high proportion of oleic acid while poppyseed oil is rich 
in linoleic acid. Thus the iodized oil prepared from oils rich in oleic acid, such as 
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peanut oil, should be given in preference to preparations based on poppyseed oil 
in public health nutrition programs to control iodine deficiency. 
• A single oral dose of iodized peanut oil supplying 200 mg I was effective in 
protecting school children living in endemic iodine deficient area for one year 
against iodine deficiency. 
• Urinary iodine concentration and thyroid volume measured by ultrasound are the 
most useful indicators for assessing iodine status and measuring the impact of 
iodized oil supplementation in school children living in an endemic iodine 
deficient area. However palpation still has a useful place in assessing iodine 
status because no sophisticated equipment is required, but it is necessary for 
observers to be adequately trained in the technique. 
• Iodine status as measured by urinary iodine concentration at baseline and 
stunting were related to the improvement of cognitive performance when children 
were dosed with iodized oil. In addition anemia and father's education played a 
role in cognition. This illustrates the role of nutrition and social factors in cognitive 
development and performance in children. 
• The use of iodized salt was correlated with urinary iodine concentration and 
thyroid volume of the population studied. However, adequate iodine status was 
not achieved through the iodized salt program and more attention will be required 
to make it a success. 
IMPLICATION FOR POLICIES TO CONTROL IODINE DEFICIENCY 
Selection of strategies 
Universal salt iodization is the main strategy for controlling iodine deficiency. 
Results showed that iodized salt has improved the iodine status of the population. 
However there is still a low awareness of the population at risk about using 
adequately iodized salt, especially when non-iodized cheaper salt is available in the 
market. More intensive social marketing strategies, improved education, better 
quality assurance and closer process monitoring of the salt iodization program are 
required. 
Oral iodized oil is the best alternative and an additional strategy to iodized salt 
for controlling iodine deficiency, especially in areas of moderate to severe iodine 
deficiency where iodized salt is unlikely to be successfully implemented soon and 
correction is needed promptly. In many such areas, an iodized oil program will be 
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necessary for at least several years, and for some remote areas it may need to be 
semi-permanent. An oral iodized oil preparation based on an oleic acid rich oil such 
as peanut oil is more effective than a preparation based on poppyseed oil. A single 
dose of oral iodized peanut oil given to moderate or severe iodine deficient school 
children annually will control iodine deficiency adequately. 
Measuring the extent of iodine deficiency and evaluating the effect of 
programs 
A commonly used parameter to access the extent of IDD in a community is 
the prevalence of goiter as assessed through thyroid palpation. However, grading of 
goiter size by palpation has large intra and inter-observer variability. Even though 
thyroid palpation has its limitations, it still has a useful place in assessing iodine 
status because no sophisticated equipment is required. Therefore, it is necessary for 
observers to be trained adequately in the technique. In addition, other indicators of 
iodine or thyroid status should be used. This study suggested that urinary iodine 
concentration and thyroid volume measured by ultrasound are the most useful 
indicators for assessing iodine status and measuring the impact of treatment among 
populations of school children. 
RECOMMENDATIONS FOR FUTURE RESEARCH 
Research on the efficacy of different preparations of iodized oil should focus 
on: 
• The metabolism of such preparations in the body to elucidate the relative rates of 
the various reactions and process involved. 
Research on iodine indicators should focus on: 
• Development of reliable and cost-effective indicators for measuring the iodine 
status of the population. 
Research on cognitive performance should focus on: 
• The relative importance of iodine supplementation in improving the cognitive 
performance of populations with multiple nutritional problems including iodine 
deficiency. 
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Research on efficacy of iodized salt should focus on: 
• Measuring the average salt consumption in the population. 
• The effect of food preparation including the method and duration of cooking and 
the spices used, on the stability of iodized salt. 
• Determining optimal levels of fortification for controlling iodine deficiency in 
populations differing in the severity of iodine deficiency and other characteristics. 
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Efficacy of different types of 
iodized oil 
Lancet 1998;351:752-753 (Letter) 
Juliawati Untoro, Werner Schultink, Rainer Gross, Clive E West, Joseph G A J 
Hautvast 
Annex 1 
Sir--Y Ingenbleek and colleagues(l) describe the preparation and use in 
severe endemic goitre of a new type of iodized oil based on rapeseed oil which is 
better than previously available preparations based on poppyseed oil. Iodized oil 
based on peanut oil was introduced in Indonesia in 1993. The composition of peanut 
oil (56% oleic acid and 26% linoleic acid) is similar to that of rapeseed oil (60% oleic 
acid and 20% linoleic acid), as reported by Ingenbleek. Apart from the scarcity of 
poppyseed oil, its high proportion of polyunsaturated fatty acids (73%) was another 
reason for seeking a new basis for iodized oil. Iodine from such oils is retained for a 
shorter time than iodine from oils with a high proportion of monounsaturated fatty 
acids (2). 
We compared the efficacy of two iodized oils: oil A (ethyl esters of iodized 
fatty acids from poppyseed oil; Lipiodol®, Laboratoire Guerbet, Roissy, France) and 
oil B (iodized peanut oil; Yodiol®, PT Kimia Farma, Jakarta, Indonesia), under 
community conditions in a randomized, single-blind, placebo-controlled trial among 
250, 8-10-year-old, Indonesian school children from Cilacap district, Central-Java, 
which is an area endemic for iodine deficiency disorders. 
Children were de-wormed with 400 mg albendazole (SmithKline Beecham, 
Indonesia) 1 week before being supplemented. A urine sample was collected 
between 08.00 h and 12.00 h on 2 consecutive days at baseline and at 4 and 12 
weeks' follow-up. Further samples will be taken at 25 and 50 weeks. Urinary iodine 
excretion was measured in duplicate and the average calculated for each child. The 
table shows details about treatment and preliminary results. Urinary iodine excretion 
at baseline was closely similar between groups. At 4 and 12 weeks urinary iodine 
excretion of all supplemented groups was significantly higher than in the placebo 
group (Mann-Whitney; P<0.001). Urinary iodine excretion of the group 
supplemented with oil A was similar to the urinary iodine excretion of the 200 mg oil 
B group, and significantly lower than urinary iodine excretion of the 400 mg oil B 
group (P <0.001) at both 4 and 12 weeks. 
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Table 1. Median urinary iodine excretion at the baseline and at 4 and 12 weeks after oral 
supplementation of school children with different types of iodized oil. 
Treatment* 
Iodized oil A 
400 mg 
Iodized oil B 
200 mg 
Iodized oil B 
400 mg 
Iodized oil B 
800 mg 
Placebo 
n 
49 
50 
51 
50 
51 
Median 
Baseline 
43.0 
[8.0-195.5] 
46.5 
[20.0-157.0] 
43.5 
[13.0-143.5] 
46.3 
[12.0-212.5] 
47.5 
[6.5-132.5] 
urinary iodine excretion [range], ng/L § 
4 week 
465.0 *H 
[51.5-1450.0] 
533.0 *H 
[124.5-3625.0] 
925.0 t# 
[147.5-3700.0] 
1517.5*** 
[430.0-6450.0] 
67.0 § t t 
[15.5-385.0] 
12 week 
239.0 * ! 
[72.5-840.0] 
347.5 *U 
[95.5-1797.0] 
555.0 t# 
[115.0-1626.0] 
1119.0*** 
[355.0-2590.0] 
82.5 § t t 
[14.0-199.0] 
* Iodized oil A, iodized fatty acid ethyl esters from poppy-seed oil; iodized oil B, iodized 
peanut oil; placebo, peanut oil. 
t Based on the average urinary iodine excretion of two consecutive days for each person 
Within-group changes compared to baseline: $, P<0.001; §, P<0.05 (Wilcoxon Matched-Pairs) 
Different letters (11, #, **, t t j indicate significant differences between groups of treatment 
(P<0.0001, Kruskal Wallis) 
These results indicate higher iodine retention from iodized peanut oil than with ethyl 
esters of iodized fatty acids prepared from poppyseed oil. The short-term efficacy of 
iodized peanut oil, having a fairly high percentage of monosaturated fatty acid, is 
greater than that of the poppyseed oil preparation. This finding is in accord with that 
of Ingenbleek et al. (1). The continued follow-up will show whether iodized peanut oil 
will allow less frequent supplementation while maintaining a median urinary iodine 
excretion higher than 100 ug/L. Iodized oil capsules based on oils with a high 
percentage of monounsaturated fatty acids would allow eradication of iodine 
deficiency in areas in which immediate action is required. 
117 
Annex 1 
REFERENCES 
1. Ingenbleek Y, Jung L, Ferard G, Bordet F, Goncalves AM, Dechoux L. Iodised 
rapeseed oil for eradication of severe endemic goitre. Lancet 1997;350:1542-5. 
2. Van der Heide D, de Goeje MJ, van der Bent C. The effectiveness of oral administered 
iodized oil in rat and man. Annales d'endocrinologie 1989; 50: 116 (abst). 
118 
Summary 
The research described in this thesis focused on the use of oral iodized oil to 
control iodine deficiency in school children living in an endemic iodine deficient area 
in Indonesia. Iodine deficiency is responsible for a series of disabilities which are 
collectively known as iodine deficiency disorders (IDD). Although goiter is the most 
manifest sign, iodine deficiency results in irreversible brain damage in the fetus and 
infant, retarded mental and psycho-motor development in the child, and also 
impaired reproductive function. The World Summit for Children in 1990 committed 
governments to eradicate iodine deficiency by the year 2000. Universal salt 
iodization has been set as the main strategy employed to eradicate iodine 
deficiency, and about 60% of all edible salt worldwide is iodized. 
Various strategies have been used in Indonesia to combat iodine deficiency. 
The prevalence of goiter among school children decreased during the 1980s and 
adequately iodized salt used in households increased from one third in 1983-1984 to 
nearly one half in 1995. Legislation was promulgated in 1994 to bring about salt 
iodization with a minimum level of fortification set at 30 mg l/kg salt. Although the 
production and use of iodized salt to control iodine deficiency is now widespread, 
additional strategies are required where iodized salt cannot be made available in the 
short term or only with difficulty in the long term. The best alternative is probably oral 
iodized oil which is the subject of this thesis. 
There is evidence from previous studies that a single oral dose of iodized oil 
is effective in controlling iodine deficiency for one to two years. The most widely 
available preparation is iodized poppyseed oil. Previous work has shown that iodine 
from iodized oil prepared from ethyl oleate was retained longer in both man and rats 
than that prepared from ethyl linoleate or ethyl esters of fatty acids from poppyseed 
oil which has a high proportion of linoleic acid and a low proportion of oleic acid. Oils 
rich in oleic acid, such as peanut oil, also have the advantage that they are cheaper 
than poppyseed oil. 
Thus the efficacy of orally administered iodized peanut oil was compared with 
that of iodized poppyseed oil among school children aged 8-10 years living in an 
endemic iodine deficient area in Indonesia. In addition, the performance of different 
outcome indicators of iodine deficiency, the impact of nutritional status and iodine 
supplementation on cognitive performance, as well as the effectiveness of 
introduction of salt iodization in the population were investigated. 
A single oral dose of iodized peanut oil compared to a single oral dose of 
iodized poppyseed oil resulted in three times higher iodine retention leading to a 
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period of protection twice as long. While this study was being carried out, similar 
results were obtained by others using iodized oil prepared from rapeseed oil which is 
also rich in oleic acid. Thus iodized oil prepared from oleic acid rich oils, such as 
peanut oil and rapeseed oil, should be given preference to poppyseed oil in 
programs to control iodine deficiency. 
Iodine status and the effect of intervention in the population, can be 
measured using various outcome indicators. The selection of an indicator is 
dependent on the acceptance of the indicator by the target population and field staff 
performing the assessment, on the ease of use in field conditions, and on the 
available resources in terms of money, laboratory equipment and staff. Above all, 
the indicator must be valid. So far, the number of studies comparing the relative 
sensitivity and specificity of indicators for assessing iodine status of a population is 
limited and they have given conflicting results. We evaluated different outcome 
indicators for assessing iodine status and measuring the effect of oral iodized oil 
treatment. We found that urinary iodine concentration and thyroid volume measured 
by ultrasound are the most useful indicators for assessing iodine status and 
measuring the impact of iodized oil supplementation among iodine deficient school 
children. The other indicators, i.e.: palpation and serum concentrations of thyroid 
stimulating hormone (TSH) and free thyroxine (FT4), did not show concordance for 
assessing iodine deficiency or the impact of treatment. Serum concentrations of 
thyroglobulin were also shown to be of limited value in assessing iodine status. 
Although these data highlight the limitations of thyroid palpation, this method still has 
a useful place in assessing iodine status because no sophisticated equipment is 
required. However it is necessary for observers to be trained in the technique. 
Nutritional supplementation of undernourished children is known to have a 
beneficial effect on their intellectual capacity. The factors related to cognitive 
performance and the effect of oral dosing with iodized oil were examined using 
Cattell's culturally fair intelligence test. Median cognitive performance was low, 32% 
of the children were underweight, 58% were stunted, 3% were wasted, and 40% 
were anemic. Father's education and hemoglobin concentration were the main 
determinants of cognitive performance at baseline, and urinary iodine concentration 
and stunting were the most important determinants for improvement in cognitive 
performance after supplementation with iodized oil. These results illustrate the role 
of nutrition and social factors in cognitive development and performance in children. 
Data on the effectiveness of iodized salt for controlling iodine deficiency is still 
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scanty. After one year of introduction of salt iodization, the proportion of households 
using adequately iodized salt increased significantly, from 2% to 54%, but there was 
inconsistency in its use within households during the study period. The use of 
iodized salt was related to urinary iodine concentration and thyroid volume. However 
the prevalence of goiter measured by palpation remained at 17% and serum 
concentrations of TSH and FT4 did not respond to the salt iodization, indicating the 
poor performance of these indicators as mentioned above. These findings indicate 
that iodine prophylaxis using iodized salt is not only simply a matter of passing 
legislation, but should also include advocacy, education, marketing, an overall 
system of quality assurance and monitoring of the salt iodization program. 
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Het onderzoek dat in dit proefschrift beschreven wordt, was gericht op het 
gebruik van gejodeerde olie om jodiumtekort te bestrijden bij schoolkinderen 
woonachtig in een endemisch jodium deficient gebied in Indonesie. Jodiumtekort is 
verantwoordelijk voor een aantal aandoeningen die bekend staan als het 
jodiumtekort syndroom (IDD). Hoewel struma het meest zichtbare symptoom is, 
geeft jodiumtekort ook onomkeerbare hersenschade in de foetus en zuigeling, 
vertraagde mentale en psycho-motorische ontwikkeling van het kind en ook een 
verminderde voortplantingsfunctie. Tijdens de World Summit for Children in 1990 
verplichtten regeringen zich om jodium tekort voor het jaar 2000 uit te bannen. Het 
joderen van zout is de belangrijkste strategie om het jodiumtekort te bestrijden en 
wereldwijd is ongeveer 60% van het consumptiezout gejodeerd. 
In Indonesie zijn diverse strategieen toegepast om jodiumtekort te bestrijden. 
De prevalence van struma onder schoolkinderen is gedurende de jaren tachtig 
gedaald. Bovendien steeg het gebruik van zout dat voldoende gejodeerd is. In 1983-
1984 gebruikte slechts een derde van de huishoudens dit zout terwijl dit in 1995 
gestegen was tot bijna de helft van de huishoudens. In 1994 werd in de 
Indonesische wet vastgelegd dat al het zout ten minste 30mg jodium per kg moet 
bevatten. Hoewel de productie en het gebruik van gejodeerd zout ter bestrijding van 
jodiumtekort nu wijdverspreid is, zijn aanvullende strategieen nodig als gejodeerd 
zout niet snel beschikbaar is of alleen met moeite op lange termijn beschikbaar kan 
worden. Het beste alternatief is waarschijnlijk orale toediening van gejodeerde olie, 
het onderwerp van dit proefschrift. 
Uit eerdere studies is gebleken dat een eenmalige dosis gejodeerde olie 
effectief is in het bestrijden van jodium tekorten voor een periode van 1 tot 2 jaar. 
Het meest beschikbare preparaat is gejodeerde papaverzaadolie. Eerder werk heeft 
laten zien dat jodium afkomstig van gejodeerde olie gemaakt van ethyl oleaat langer 
beschikbaar bleef in de mens en in ratten vergeleken met olie van ethyl linoleaat of 
ethyl esters van vetzuren van papaverzaadolie met een hoog gehalte aan linolzuur 
en een laag gehalte aan oliezuur. Olien rijk aan oliezuur, zoals pindaolie, hebben 
ook als voordeel dat ze goedkoper zijn dan papaverzaadolie. 
De doeltreffendheid van oraal toegediende gejodeerde pindaolie werd 
vergeleken met dat van gejodeerde papaverzaadolie in schoolkinderen van 8-10 
jaar woonachtig in een endemisch jodium deficient gebied in Indonesie. Verder 
werden verschillende indicatoren van jodiumtekort, het effect van voedingsstatus en 
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jodiumsuppletie op de cognitieve verrichting als ook de effectiviteit van de introductie 
van het joderen van zout in de populatie, bestudeerd. 
Een eenmalige orale dosis gejodeerde pindaolie resulteerde in een 3 maal zo 
hoge retentie van jodium met als gevolg een twee maal zo lange beschermende 
periode. Terwijl deze studie werd uitgevoerd, werden door anderen vergelijkbare 
resultaten met gejodeerde olie gemaakt van raapzaadolie, wat ook rijk is aan 
oliezuur. In programma's om jodiumtekort tegen te gaan, zou dus de voorkeur 
gegeven moeten worden aan gejodeerde olie bereid met oliezuurrijke olien, zoals 
pindaolie en raapzaadolie, boven gejodeerde papaverzaadolie. 
De jodiumstatus en het effect van interventies kan worden bepaald met 
verschillende indicatoren. De selectie van een indicator is afhankelijk van de 
acceptatie van de doelgroep en het personeel dat de meting moet uitvoeren, de 
bruikbaarheid van de indicator onder onderzoeksomstandigheden en de 
beschikbare bronnen in termen van geld, laboratoriumuitrusting en personeel. 
Bovenal moet de indicator valide zijn. Tot zover is het aantal studies beperkt welke 
de sensitiviteit en specificiteit van indicatoren voor de bepaling van de jodiumstatus 
van een populatie onderzoeken. Bovendien zijn de resultaten tegenstrijdig. We 
hebben verschillende indicatoren geevalueerd voor de bepaling van de jodiumstatus 
en voor het meten van het effect van inname van gejodeerde olie. We vonden dat 
de jodiumconcentratie in de urine en de grootte van de schildklier gemeten door 
ultrasound de meest bruikbare indicatoren zijn voor het meten van de jodiumstatus 
en het meten van de uitwerking van suppletie met gejodeerde olie bij schoolkinderen 
met een jodiumtekort. 
De andere indicatoren, zijnde: palpatie en serum concentraties van het 
schildklier stimulerend hormoon (TSH) en vrij thyroxine (FT4) stemden niet overeen 
wat betreft het meten van jodiumtekort.of de uitwerking van de behandeling. 
Serumconcentraties van thyroglobuline bleken ook een beperkte waarde te hebben 
voor de bepaling van de jodiumstatus. Hoewel deze gegevens de beperkingen van 
schildklierpalpaties benadrukken, heeft deze methode nog steeds een bruikbare 
plaats in de bepaling van de jodiumstatus, omdat er geen geavanceerde apparatuur 
voor nodig is. Het is echter belangrijk dat de waarnemers de techniek goed onder de 
knie hebben. 
Het is bekend dat de aanvulling van de voeding van ondervoede kinderen 
een gunstig effect heeft op hun intellectuele mogelijkheden. De aan de cognitieve 
verrichtingen gerelateerde factoren en het effect van orale dosering van gejodeerde 
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olie werden bestudeerd met behulp van de 'Cattell's culturally fair intelligency test'. 
Uit de test bleek dat de mediaan van de cognitieve verrichtingen laag was. 
Bovendien bleek 32% van de kinderen te licht te zijn voor hun leeftijd, 58% was te 
klein voor hun leeftijd, 3% had een te laag gewicht voor hun lengte en 40% had 
ijzergebreksanemie. De opleiding van de vader en de hemoglobineconcentratie van 
het kind waren de belangrijkste determinanten van de cognitieve verrichtingen aan 
het begin van de studie. De jodiumconcentratie in de urine en een te geringe lengte 
voor de leeftijd waren de belangrijkste determinanten voor verbetering in de 
cognitieve verrichting na suppletie met gejodeerde olie. Deze resultaten illustreren 
de rol van voeding en sociale factoren in de cognitieve ontwikkeling en verrichtingen 
van kinderen. 
Gegevens over de effectiviteit van gejodeerd zout voor de bestrijding van 
jodiumtekort zijn schaars. Een jaar na de introductie van gejodeerd zout steeg het 
deel van de huishoudens dat zout gebruikte dat voldoende gejodeerd is significant 
van 2% naar 54%. Het werd echter niet consequent gebruikt binnen huishoudens 
gedurende de studieperiode. 
De jodiumconcentratie in de urine en de grootte van de schildklier waren 
gerelateerd aan het gebruik van gejodeerd zout. Echter, de prevalence van struma, 
zoals gemeten met palpatie bleef op 17%. De serumconcentraties van TSH en FT4 
reageerden niet op de jodering van het zout. Dit geeft aan dat, zoals reeds eerder 
vermeld, dit geen goede indicatoren zijn. Deze bevindingen duiden aan dat het 
gebruik van jodiumprofylaxe met behulp van gejodeerd zout niet slechts een 
aanpassing van de wetgeving vereist, maar daarnaast kan het 
zoutjoderingsprogramma ook niet zonder promotie, voorlichting, marketing en een 
allesomvattend systeem van kwaliteitscontrole. 
125 
Ringkasan 
Penelitian ini berfokus pada penggunaan kapsul minyak beryodium untuk 
menanggulangi kekurangan yodium pada anak sekolah di daerah endemik 
kekurangan yodium di Indonesia. Kekurangan yodium berperanan dalam suatu seri 
bermacam gangguan yang secara keseluruhan disebut gangguan akibat 
kekurangan yodium (GAKI). Meskipun gondok adalah gangguan yang paling nyata, 
kekurangan yodium juga dapat menyebabkan gangguan perkembangan saraf pada 
fetus dan bayi, keterlambatan perkembangan mental dan psikomotor pada anak-
anak dan gangguan sistem reproduksi. Konferensi World Summit for Children tahun 
1990 mencetuskan komitment pemerintah untuk mengentaskan kekurangan yodium 
pada tahun 2000. Program iodisasi garam merupakan strategi utama dalam 
penanggulangan GAKI, dan sekitar 60% garam konsumsi yang tersedia di seluruh 
dunia, telah diiodisasi. 
Berbagai strategi digunakan di Indonesia, untuk menanggulangi kekurangan 
yodium. Prevalensi gondok dari anak sekolah menunjukkan penurunan pada tahun 
1980 an dan penggunaan garam beryodium di tingkat rumah tangga meningkat dari 
sepertiga di tahun 1983-1984 menjadi hampir setengah di tahun 1995. 
Kebijaksanaan pemerintah tentang penggunaan garam beryodium dituangkan 
dalam Keputusan Presiden pada tahun 1994, yang menetapkan iodisasi garam 
pada konsentrasi minimal 30 mg l/kg garam. Meskipun produksi dan penggunaan 
garam beryodium untuk menganggulangi GAKI telah meluas, strategi lain diperlukan 
untuk daerah-daerah dimana garam beryodium tidak dapat diterapkan dalam jangka 
waktu pendek atau hanya dapat diterapkan pada jangka waktu panjang dengan 
tingkat kesulitan yang cukup tinggi. Alternatif yang terbaik kemungkinan adalah 
kapsul minyak beryodium yang merupakan topik dari thesis ini. 
Hasil penelitian-penelitian terdahulu menunjukkan bahwa pemberian dosis 
tunggal kapsul beryodium dapat secara efektif menanggulangi kekurangan yodium 
untuk jangka waktu satu sampai dua tahun. Produk minyak beryodium yang paling 
banyak tersedia saat ini adalah minyak beryodium dari poppyseed. Penelitian 
terdahulu menunjukkan bahwa yodium dari minyak beryodium dari preparasi ethyl 
oleat memiliki daya retensi dalam tubuh manusia maupun tikus, lebih lama dari 
preparasi ethyl oleate atau ethyl esters asam lemak dari minyak poppyseed yang 
memiliki proporsi kandungan asam linoleat yang tinggi dan proporsi asam oleat yang 
relatif rendah. Minyak yang kaya kandungan asam oleat, seperti minyak kacang, 
juga memiliki keunggulan bahwa harganya relatif lebih murah dari minyak 
poppyseed. 
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Oleh karena itu, penelitian ini bertujuan untuk membandingkan efikasi dari 
kapsul minyak kacang dengan kapsul minyak poppyseed pada anak sekolah usia 8-
10 tahun. Selain itu, penggunaan berbagai indikator dari status yodium, dampak 
suplementasi yodium terhadap fungsi kognitif juga efektifitas dari iodisasi garam 
pada masyarakat diteliti lebih lanjut. 
Dosis tunggal kapsul yodium minyak kacang menunjukkan retensi yodium 
tiga kali lebih tinggi dan menghasilkan masa proteksi dua kali lebih lama 
dibandingkan dengan dosis tunggal kapsul yodium minyak poppyseed. Pada saat 
studi ini dilakukan, hasil yang sama didapatkan pada preparasi yodium minyak 
rapeseed, yang juga kaya kandungan asam oleatnya. Oleh karena itu, kapsul 
minyak beryodium yang kaya kandungan asam oleat, seperti minyak kacang dan 
minyak rapeseed, adalah merupakan produk yang akan lebih disukai dibanding 
dengan preparasi minyak beryodium poppyseed, dalam menanggulangi GAKI. 
Status yodium dan dampak dari intervensi pada masyarakat, dapat diukur 
dengan berbagai indikator. Pemilihan indikator adalah tergantung dari penerimaan 
indikator tersebut oleh populasi yang diukur dan petugas lapang yang melakukan 
pengukuran, kemudahan melakukan pengukuran tersebut di lapangan, dan 
ketersediaan sumber daya dalam pengertian dana, peralatan laboratorium dan staff. 
Selain itu, yang paling utama adalah indikator tersebut harus valid. Hingga saat ini, 
berbagai penelitian dengan membandingkan sensitifitas and spesifisitas dari 
bermacam indikator untuk mengukur status yodium pada masyarakat sangat 
terbatas dan hasilnya saling bertentangan. Penelitian ini mengevaluasi berbagai 
macam indikator untuk mengukur status yodium dan dampak dari perlakuan kapsul 
beryodium. Hasil penelitian ini menunjukkan bahwa konsentrasi yodium urin dan 
volume tiroid merupakan indikator-indikator yang terbaik untuk mengukur status 
yodium dan dampak dari perlakuan kapsul beryodium pada anak sekolah. Indikator-
indikator yang lain, yaitu: palpasi tiroid, konsentrasi serum thyroid stimulating 
hormone (TSH) dan thyroxine bebas (FT4), tidak menunjukkan hasil yang seiring 
dalam mengukur status kekurangan yodium dan dampak dari perlakuan. 
Konsentrasi serum thyroglobulin juga menunjukkan hasil yang kurang memuaskan 
dalam mengukur status yodium. Meskipun data menunjukkan bahwa palpasi tiroid 
memiliki kekurangan, namun palpasi tiroid tetap memiliki peranan dalam mengukur 
status yodium, karena tidak diperlukan peralatan yang canggih. Akan tetapi, 
dibutuhkan training yang cukup dalam teknik palpasi. 
Suplementasi zat gizi tertentu pada anak-anak kekurangan zat gizi tersebut 
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menunjukkan hasil yang positif bagi perkembangan kapasitas intelektual mereka. 
Penelitian ini juga bertujuan untuk menginvestigasi faktor-faktor yang berkaitan 
dengan fungsi kognitif dan dampak dari penggunaan kapsul minyak beryodium 
terhadap perkembangan fungsi kognitif yang diukur dengan Cattell's culturally fair 
intelligence test. Nilai median dari fungsi kognitif anak-anak dalam penelitian ini 
adalah relatif rendah, selain itu 32% dari populasi memiliki berat badan kurang 
(berat badan menurut usia), 58% memiliki tinggi badan kurang (tinggi badan 
menurut usia), 3% menderita berat menurut tinggi badan kurang, dan 40% 
menderita anemia gizi. Penelitian ini menunjukkan bahwa pendidikan ayah dan 
status hemoglobin darah memiliki peranan dalam fungsi kognitif, sementara 
konsentrasi yodium urin dan tinggi badan menurut usia merupakan faktor yang 
paling menentukan perkembangan fungsi kognitif setelah suplementasi dengan 
kapsul minyak beryodium. Hasil penelitian ini mengilustrasikan peranan dari faktor 
gizi dan faktor sosial dalam perkembangan fungsi kognitif pada anak-anak. 
Data tentang efektifitas garam beryodium dalam menanggulangi kekurangan 
yodium masih sangat terbatas. Setelah satu tahun penerapan iodisasi garam, 
proporsi rumah tangga yang menggunakan garam beryodium dengan konsentrasi 
yang memenuhi persyaratan, meningkat dari 2% ke 54%, namun ditemukan adanya 
ketidak konsistenan dalam penggunaan garam beryodium di rumah tangga. 
Penelitian ini menunjukkan bahwa penggunaan garam beryodium berkaitan dengan 
status yodium yang diindikasikan dengan konsentrasi yodium urin dan volume tiroid. 
Namun prevalensi gondok menurut palpasi tetap pada 17% dan konsentrasi serum 
TSH dan FT4 tidak menunjukkan respon terhadap penggunaan garam beryodium, 
hal ini menunjukkan kelemahan performan dari indikator tersebut seperti yang telah 
dipaparkan terdahulu. Hasil penelitian ini mengindikasikan bahwa dalam penerapan 
penggunaan garam beryodium selain peraturan, dibutuhkan pula promosi, 
pendidikan, pemasaran, dan sistem yang menyeluruh dalam pengendalian mutu 
dan pemonitoran program iodisasi garam. 
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